10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

Form 10-Q

(Mark One)

ý QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended December 31, 2013

or

¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from                     to                    

Commission file number 000-04065

Lancaster Colony Corporation

(Exact name of registrant as specified in its charter)

Ohio	13-1955943
(State or other jurisdiction of incorporation or organization)	(I.R.S. Employer Identification No.)
37 West Broad Street Columbus, Ohio	43215
(Address of principal executive offices)	(Zip Code)

614-224-7141

(Registrant’s telephone number, including area code)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  ý    No  ¨

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).    Yes  ý    No  ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):

Large Accelerated filer	ý	Accelerated filer	¨
Non-accelerated filer	o  (Do not check if a smaller reporting company)	Smaller Reporting Company	¨

Indicate by check mark whether the registrant is a shell company (as defined by Rule 12b-2 of the Exchange Act).    Yes  ¨    No  ý

As of January 22, 2014, there were approximately 27,291,000 shares of Common Stock, without par value, outstanding.

LANCASTER COLONY CORPORATION AND SUBSIDIARIES

TABLE OF CONTENTS

PART I – FINANCIAL INFORMATION		3
Item 1.	Condensed Consolidated Financial Statements (unaudited):
	Condensed Consolidated Balance Sheets – December 31, 2013 and June 30, 2013	3
	Condensed Consolidated Statements of Income – Three and Six Months Ended December 31, 2013 and 2012	4
	Condensed Consolidated Statements of Comprehensive Income – Three and Six Months Ended December 31, 2013 and 2012	5
	Condensed Consolidated Statements of Cash Flows – Six Months Ended December 31, 2013 and 2012	6
	Notes to Condensed Consolidated Financial Statements	7
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	15
Item 3.	Quantitative and Qualitative Disclosures About Market Risk	20
Item 4.	Controls and Procedures	20
PART II – OTHER INFORMATION		21
Item 1A.	Risk Factors	21
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	21
Item 6.	Exhibits	21
SIGNATURES		22
INDEX TO EXHIBITS		23

2

PART I – FINANCIAL INFORMATION

Item 1. Condensed Consolidated Financial Statements

LANCASTER COLONY CORPORATION AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

(UNAUDITED)

(Amounts in thousands, except share data)	December 31,   2013			June 30,   2013
ASSETS
Current Assets:
Cash and equivalents	$	176,263		$	123,386
Receivables (less allowance for doubtful accounts, December-$1,021; June-$822)	86,862			70,398
Inventories:
Raw materials	30,973			35,012
Finished goods and work in process	61,567			74,139
Total inventories	92,540			109,151
Deferred income taxes and other current assets	17,208			23,123
Total current assets	372,873			326,058
Property, Plant and Equipment:
Land, buildings and improvements	144,784			144,206
Machinery and equipment	290,188			289,051
Total cost	434,972			433,257
Less accumulated depreciation	250,767			243,562
Property, plant and equipment-net	184,205			189,695
Other Assets:
Goodwill	89,840			89,840
Other intangible assets-net	5,849			6,322
Other noncurrent assets	7,921			8,049
Total	$	660,688		$	619,964
LIABILITIES AND SHAREHOLDERS’ EQUITY
Current Liabilities:
Accounts payable	$	42,554		$	41,890
Accrued liabilities	35,498			35,287
Total current liabilities	78,052			77,177
Other Noncurrent Liabilities	23,175			23,291
Deferred Income Taxes	18,755			18,274
Shareholders’ Equity:
Preferred stock-authorized 3,050,000 shares; outstanding-none
Common stock-authorized 75,000,000 shares; outstanding – December-27,290,849 shares; June-27,323,721 shares	103,826			102,622
Retained earnings	1,180,315			1,139,213
Accumulated other comprehensive loss	(8,256		)	(8,391		)
Common stock in treasury, at cost	(735,179		)	(732,222		)
Total shareholders’ equity	540,706			501,222
Total	$	660,688		$	619,964

See accompanying notes to condensed consolidated financial statements.

3

LANCASTER COLONY CORPORATION AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF INCOME

(UNAUDITED)

	Three Months Ended   December 31,						Six Months Ended   December 31,
(Amounts in thousands, except per share data)	2013			2012			2013			2012
Net Sales	$	335,550		$	326,155		$	621,406		$	617,131
Cost of Sales	247,242			244,499			471,460			469,758
Gross Margin	88,308			81,656			149,946			147,373
Selling, General and Administrative Expenses	28,937			29,031			52,975			54,176
Operating Income	59,371			52,625			96,971			93,197
Other Income:
Other income-Continued Dumping and Subsidy Offset Act	91			293			91			293
Interest income and other-net	(119		)	(39		)	(167		)	(25		)
Income Before Income Taxes	59,343			52,879			96,895			93,465
Taxes Based on Income	20,109			17,602			32,860			31,526
Net Income	$	39,234		$	35,277		$	64,035		$	61,939
Net Income Per Common Share:
Basic	$	1.44		$	1.29		$	2.35		$	2.26
Diluted	$	1.44		$	1.28		$	2.34		$	2.26
Cash Dividends Per Common Share	$	0.44		$	5.38		$	0.84		$	5.74
Weighted Average Common Shares Outstanding:
Basic	27,244			27,243			27,256			27,236
Diluted	27,299			27,273			27,306			27,268

See accompanying notes to condensed consolidated financial statements.

4

LANCASTER COLONY CORPORATION AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

(UNAUDITED)

	Three Months Ended   December 31,						Six Months Ended   December 31,
(Amounts in thousands)	2013			2012			2013			2012
Net Income	$	39,234		$	35,277		$	64,035		$	61,939
Other Comprehensive Income:
Defined Benefit Pension and Postretirement Benefit Plans:
Amortization of loss, before tax	108			167			216			334
Amortization of prior service asset, before tax	(1		)	(1		)	(2		)	(2		)
Total Other Comprehensive Income, Before Tax	107			166			214			332
Tax Attributes of Items in Other Comprehensive Income:
Amortization of loss, tax	(39		)	(62		)	(79		)	(124		)
Amortization of prior service asset, tax	—			—			—			—
Total Tax Expense	(39		)	(62		)	(79		)	(124		)
Other Comprehensive Income, Net of Tax	68			104			135			208
Comprehensive Income	$	39,302		$	35,381		$	64,170		$	62,147

See accompanying notes to condensed consolidated financial statements.

5

LANCASTER COLONY CORPORATION AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(UNAUDITED)

	Six Months Ended   December 31,
(Amounts in thousands)	2013			2012
Cash Flows From Operating Activities:
Net income	$	64,035		$	61,939
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	10,649			9,971
Deferred income taxes and other noncash changes	672			(848		)
Stock-based compensation expense	1,200			1,623
Gain on sale of property	(6		)	(41		)
Pension plan activity	(122		)	(30		)
Changes in operating assets and liabilities:
Receivables	(16,666		)	(18,153		)
Inventories	16,611			9,160
Other current assets	6,716			(1,385		)
Accounts payable and accrued liabilities	983			5,515
Net cash provided by operating activities	84,072			67,751
Cash Flows From Investing Activities:
Payments on property additions	(4,370		)	(10,359		)
Proceeds from sale of property	6			148
Other-net	(656		)	(359		)
Net cash used in investing activities	(5,020		)	(10,570		)
Cash Flows From Financing Activities:
Purchase of treasury stock	(2,957		)	—
Payment of dividends	(22,933		)	(156,755		)
Excess tax benefit from stock-based compensation	39			459
Decrease in cash overdraft balance	(324		)	—
Net cash used in financing activities	(26,175		)	(156,296		)
Net change in cash and equivalents	52,877			(99,115		)
Cash and equivalents at beginning of year	123,386			191,636
Cash and equivalents at end of period	$	176,263		$	92,521
Supplemental Disclosure of Operating Cash Flows:
Cash paid during the period for income taxes	$	25,016		$	32,043

See accompanying notes to condensed consolidated financial statements.

6

LANCASTER COLONY CORPORATION AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Tabular amounts in thousands, except per share data)

Note 1 – Summary of Significant Accounting Policies

Basis of Presentation

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) for interim financial information and SEC Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. In our opinion, the interim condensed consolidated financial statements reflect all adjustments necessary for a fair presentation of the results of operations and financial position for such periods. All such adjustments reflected in the interim condensed consolidated financial statements are considered to be of a normal recurring nature. The results of operations for any interim period are not necessarily indicative of results for the full year. Accordingly, these financial statements should be read in conjunction with the financial statements and notes thereto contained in our 2013 Annual Report on Form 10-K. Unless otherwise noted, the term “year” and references to a particular year pertain to our fiscal year, which begins on July 1 and ends on June 30; for example, 2014 refers to fiscal 2014, which is the period from July 1, 2013 to June 30, 2014.

Subsequent Events

On January 30, 2014, we sold effectively all of the net operating assets of our candle manufacturing and marketing operations for approximately $28 million in cash, subject to customary post-closing adjustments. Net proceeds from the sale, as subject to the customary post-closing adjustments, are expected to total approximately $27 million, exclusive of the tax benefit anticipated to be realized from the loss incurred. The transaction is expected to result in a pretax loss of approximately $43 to $45 million, which will be recorded in the quarter ended March 31, 2014. See Note 10 for net sales and operating income information related to the Glassware and Candles segment.

The assets and liabilities of our sold operations were as follows:

	December 31,   2013		June 30,   2013
Cash	$	1	$	1
Receivables	26,594		14,061
Inventory	30,974		41,342
Other current assets	422		573
Property, plant and equipment	20,996		21,621
Other noncurrent assets	1,157		980
Total Assets	$	80,144	$	78,578
Accounts payable	$	4,029	$	5,431
Accrued liabilities	2,900		2,685
Total Liabilities	$	6,929	$	8,116

Property, Plant and Equipment

Property, plant and equipment are stated at cost less accumulated depreciation. Purchases of property, plant and equipment included in accounts payable and excluded from the property additions and the change in accounts payable in the Condensed Consolidated Statements of Cash Flows were as follows:

	December 31,
	2013		2012
Construction in progress in accounts payable	$	70	$	3,393

7

LANCASTER COLONY CORPORATION AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Tabular amounts in thousands, except per share data)

Earnings Per Share

Earnings per share (“EPS”) is computed based on the weighted average number of shares of common stock and common stock equivalents (restricted stock and stock-settled stock appreciation rights) outstanding during each period. Unvested shares of restricted stock granted to employees are considered participating securities since employees receive nonforfeitable dividends prior to vesting and, therefore, are included in the earnings allocation in computing EPS under the two-class method. Basic EPS excludes dilution and is computed by dividing income available to common shareholders by the weighted average number of common shares outstanding during the period. Diluted EPS is computed by dividing income available to common shareholders by the diluted weighted average number of common shares outstanding during the period, which includes the dilutive potential common shares associated with nonparticipating restricted stock and stock-settled stock appreciation rights.

Basic and diluted net income per common share were calculated as follows:

	Three Months Ended   December 31,						Six Months Ended   December 31,
	2013			2012			2013			2012
Net income	$	39,234		$	35,277		$	64,035		$	61,939
Net income available to participating securities	(53		)	(246		)	(87		)	(299		)
Net income available to common shareholders	$	39,181		$	35,031		$	63,948		$	61,640
Weighted average common shares outstanding – basic	27,244			27,243			27,256			27,236
Incremental share effect from:
Nonparticipating restricted stock	3			4			4			4
Stock-settled stock appreciation rights	52			26			46			28
Weighted average common shares outstanding – diluted	27,299			27,273			27,306			27,268
Net income per common share – basic	$	1.44		$	1.29		$	2.35		$	2.26
Net income per common share – diluted	$	1.44		$	1.28		$	2.34		$	2.26

Reclassifications Out of Accumulated Other Comprehensive Loss

The following table presents the amounts reclassified out of accumulated other comprehensive loss by component:

	Three Months Ended   December 31,						Six Months Ended   December 31,
	2013			2012			2013			2012
Accumulated other comprehensive loss at beginning of period	$	(8,324	)	$	(12,058	)	$	(8,391	)	$	(12,162	)
Defined Benefit Pension Plan Items:
Amortization of unrecognized net loss (1)	115			172			230			344
Postretirement Benefit Plan Items:
Amortization of unrecognized net gain (1)	(7		)	(5		)	(14		)	(10		)
Amortization of prior service asset (1)	(1		)	(1		)	(2		)	(2		)
Total other comprehensive income, before tax	107			166			214			332
Total tax expense	(39		)	(62		)	(79		)	(124		)
Other comprehensive income, net of tax	68			104			135			208
Accumulated other comprehensive loss at end of period	$	(8,256	)	$	(11,954	)	$	(8,256	)	$	(11,954	)

(1) Included in the computation of net periodic benefit income/cost. See Notes 7 and 8 for additional information.

8

LANCASTER COLONY CORPORATION AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Tabular amounts in thousands, except per share data)

Significant Accounting Policies

There were no changes to our Significant Accounting Policies from those disclosed in our 2013 Annual Report on Form 10-K.

Note 2 – Impact of Recently Issued Accounting Standards

There were no recently issued accounting pronouncements that impact our consolidated financial statements.

Note 3 – Goodwill and Other Intangible Assets

Goodwill attributable to the Specialty Foods segment was approximately $89.8 million at December 31, 2013 and June 30, 2013.

The following table summarizes our identifiable other intangible assets, all included in the Specialty Foods segment:

	December 31,   2013			June 30,   2013
Trademarks (40-year life)
Gross carrying value	$	370		$	370
Accumulated amortization	(209		)	(205		)
Net carrying value	$	161		$	165
Customer Relationships (12 to 15-year life)
Gross carrying value	$	13,020		$	13,020
Accumulated amortization	(7,332		)	(6,863		)
Net carrying value	$	5,688		$	6,157
Total net carrying value	$	5,849		$	6,322

Amortization expense for our intangible assets was as follows:

	Three Months Ended   December 31,				Six Months Ended   December 31,
	2013		2012		2013		2012
Amortization expense	$	237	$	236	$	473	$	472

Total annual amortization expense for each of the next five years is estimated to be as follows:

2015	$	946
2016	$	775
2017	$	604
2018	$	604
2019	$	604

9

LANCASTER COLONY CORPORATION AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Tabular amounts in thousands, except per share data)

Note 4 – Long-Term Debt

At December 31, 2013 and June 30, 2013, we had an unsecured credit agreement under which we may borrow, on a revolving credit basis, up to a maximum of $120 million at any one time, with potential to expand the total credit availability to $200 million based on obtaining consent of the issuing banks and certain other conditions. The facility expires on April 18, 2017, and all outstanding amounts are then due and payable. Interest is variable based upon formulas tied to LIBOR or an alternative base rate defined in the credit agreement, at our option. We must also pay facility fees that are tied to our then-applicable consolidated leverage ratio. Loans may be used for general corporate purposes. Based on the long-term nature of this facility, when we have outstanding borrowings under this facility, we will classify the outstanding balance as long-term debt.

At December 31, 2013 and June 30, 2013, we had no borrowings outstanding under this facility. At December 31, 2013, we had approximately $3.7 million of standby letters of credit outstanding, which reduced the amount available for borrowing under the credit agreement. We paid no interest for the three and six months ended December 31, 2013 and 2012. At December 31, 2013 and June 30, 2013, we were in compliance with all applicable provisions and covenants of this facility, and we exceeded the requirements of the financial covenants by substantial margins. At December 31, 2013, we were not aware of any event that would constitute a default under the facility.

The facility contains certain restrictive covenants, including limitations on indebtedness, asset sales and acquisitions. There are two principal financial covenants: an interest expense test that requires us to maintain an interest coverage ratio not less than 2.5 to 1 at the end of each fiscal quarter; and an indebtedness test that requires us to maintain a consolidated leverage ratio not greater than 3 to 1 at all times. The interest coverage ratio is calculated by dividing Consolidated EBIT (as defined more specifically in the credit agreement) by Consolidated Interest Expense (as defined more specifically in the credit agreement), and the leverage ratio is calculated by dividing Consolidated Debt (as defined more specifically in the credit agreement) by Consolidated EBITDA (as defined more specifically in the credit agreement).

Note 5 – Income Taxes

Accrued Federal income taxes of approximately $1.2 million were included in accrued liabilities, and prepaid state and local income taxes of approximately $0.6 million were included in deferred income taxes and other current assets, at December 31, 2013. Prepaid Federal, state and local income taxes of approximately $7.5 million were included in deferred income taxes and other current assets at June 30, 2013. The changes were due to the timing of tax payments.

The gross tax contingency reserve at December 31, 2013 was approximately $0.9 million and consisted of tax liabilities of approximately $0.5 million and penalties and interest of approximately $0.4 million. We have classified none of the gross tax contingency reserve as current liabilities as none of these amounts are expected to be resolved within the next 12 months. The entire liability of approximately $0.9 million was included in other noncurrent liabilities. We expect that the amount of these liabilities will change within the next 12 months; however, we do not expect the change to have a significant effect on our financial position or results of operations. We recognize interest and penalties related to these tax liabilities in income tax expense.

Note 6 – Stock-Based Compensation

Our shareholders approved the adoption of and subsequent amendments to the Lancaster Colony Corporation 2005 Stock Plan (the “2005 Plan”). The 2005 Plan reserved 2,000,000 common shares for issuance to our employees and directors, and all awards granted under the 2005 Plan will be exercisable at prices not less than fair market value as of the date of the grant. The vesting period for awards granted under the 2005 Plan varies as to the type of award granted, but generally these awards have a maximum term of five years.

Stock-Settled Stock Appreciation Rights

We use periodic grants of stock-settled stock appreciation rights (“SSSARs”) as a vehicle for rewarding certain employees with long-term incentives for their efforts in helping to create long-term shareholder value. We calculate the fair value of SSSARs grants using the Black-Scholes option-pricing model. Our policy is to issue shares upon SSSARs exercise from new shares that had been previously authorized.

10

LANCASTER COLONY CORPORATION AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Tabular amounts in thousands, except per share data)

In August 2013, we granted SSSARs under the terms of our 2005 Plan. There were no grants in the six months ended December 31, 2012. The following table summarizes information relating to the 2014 grant:

	2014
SSSARs granted	2
Weighted average grant date fair value per right	$	10.14
Assumptions used in fair value calculations:
Risk-free interest rate	0.61		%
Dividend yield	2.01		%
Volatility factor of the expected market price of our common stock	23.00		%
Weighted average expected life in years	2.68
Estimated forfeiture rate	—		%

For this grant, the volatility factor was estimated based on actual historical volatility of our stock for a time period equal to the term of the SSSARs. The expected average life was determined based on historical exercise experience for this type of grant. The SSSARs from each grant vest one-third on the first anniversary of the grant date, one-third on the second anniversary of the grant date and one-third on the third anniversary of the grant date. No SSSARs vested during the six months ended December 31, 2013 and 2012.

We recognize compensation expense over the requisite service period. Compensation expense was reflected in Cost of Sales or Selling, General and Administrative Expenses based on the grantees’ salaries expense classification and was allocated to each segment appropriately. We recorded tax benefits and gross windfall tax benefits related to SSSARs. These windfall tax benefits were included in the financing section of the Condensed Consolidated Statements of Cash Flows. The following table summarizes SSSARs compensation expense and tax benefits recorded:

	Three Months Ended   December 31,				Six Months Ended   December 31,
	2013		2012		2013		2012
Compensation expense	$	212	$	338	$	519	$	799
Tax benefits	$	75	$	118	$	182	$	279
Intrinsic value of exercises	$	70	$	594	$	88	$	1,284
Gross windfall tax benefits	$	25	$	208	$	31	$	449

The following table summarizes the activity relating to SSSARs granted under the 2005 Plan for the six months ended December 31, 2013:

	Number of Rights		Weighted Average Exercise Price		Weighted Average Remaining Contractual Life in Years	Aggregate Intrinsic Value
Outstanding at beginning of period	374		$	66.42
Exercised	(7	)	$	61.48
Granted	2		$	79.78
Forfeited	—		$	—
Outstanding at end of period	369		$	66.57	3.03	$	7,966
Exercisable and vested at end of period	105		$	60.85	1.95	$	2,865
Vested and expected to vest at end of period	360		$	66.57	3.03	$	7,770

At December 31, 2013, there was approximately $1.0 million of unrecognized compensation expense related to SSSARs that we will recognize over a weighted-average period of approximately 1.64 years.

11

LANCASTER COLONY CORPORATION AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Tabular amounts in thousands, except per share data)

Restricted Stock

We use periodic grants of restricted stock as a vehicle for rewarding our nonemployee directors and certain employees with long-term incentives for their efforts in helping to create long-term shareholder value.

In November 2013 and 2012, we granted shares of restricted stock to our seven nonemployee directors under the terms of the 2005 Plan. The following table summarizes information relating to each of these grants:

	Six Months Ended   December 31,
	2013		2012
Nonemployee directors
Restricted stock granted	6		7
Grant date fair value	$	490	$	490
Weighted average grant date fair value per award	$	84.42	$	73.29

The 2014 grant vests over a one-year period, and all of these shares are expected to vest. Dividends earned on the stock during the vesting period will be paid to the directors at the time the stock vests. The 2013 grant vested during the second quarter of 2014, and the directors were paid the related dividends.

In August 2013, we granted 200 shares of restricted stock under the terms of the 2005 Plan. The grant date fair value was approximately $16,000 and the grant date fair value per award was $79.78. The restricted stock under this employee grant vests on the third anniversary of the grant date. Under the terms of our grants, employees receive dividends on unforfeited restricted stock regardless of their vesting status. There were no grants of restricted stock to employees in the six months ended December 31, 2012. No employee restricted stock vested during the six months ended December 31, 2013 and 2012.

We recognize compensation expense over the requisite service period. Compensation expense was reflected in Cost of Sales or Selling, General and Administrative Expenses based on the grantees’ salaries expense classification and was allocated to each segment appropriately. We recorded tax benefits and gross windfall tax benefits related to restricted stock. These windfall tax benefits were included in the financing section of the Condensed Consolidated Statements of Cash Flows. The following table summarizes restricted stock compensation expense and tax benefits recorded:

	Three Months Ended   December 31,				Six Months Ended   December 31,
	2013		2012		2013		2012
Compensation expense	$	341	$	414	$	681	$	824
Tax benefits	$	120	$	144	$	239	$	288
Gross windfall tax benefits	$	6	$	9	$	8	$	10

The total fair values of restricted stock vested were as follows:

	Six Months Ended   December 31,
	2013		2012
Fair value of vested shares	$	490	$	490

12

LANCASTER COLONY CORPORATION AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Tabular amounts in thousands, except per share data)

The following table summarizes the activity relating to restricted stock granted under the 2005 Plan for the six months ended December 31, 2013:

	Number of Shares		Weighted Average Grant Date Fair Value
Unvested restricted stock at beginning of period	45		$	68.16
Granted	6		$	84.27
Vested	(7	)	$	72.94
Forfeited	—		$	—
Unvested restricted stock at end of period	44		$	69.61

At December 31, 2013, there was approximately $1.5 million of unrecognized compensation expense related to restricted stock that we will recognize over a weighted-average period of approximately 1.34 years.

Note 7 – Pension Benefits

We sponsor multiple defined benefit pension plans that have covered certain union workers. However, as a result of prior-years' restructuring activities, for all periods presented, we no longer have any active employees continuing to accrue service cost or otherwise eligible to receive plan benefits. Benefits being paid under the plans are primarily based on negotiated rates and years of service. We contribute to these plans at least the minimum amount required by regulation.

The following table summarizes the components of net periodic benefit income for our pension plans:

	Three Months Ended   December 31,						Six Months Ended   December 31,
	2013			2012			2013			2012
Components of net periodic benefit income
Interest cost	$	438		$	408		$	876		$	816
Expected return on plan assets	(614		)	(595		)	(1,228		)	(1,190		)
Amortization of unrecognized net loss	115			172			230			344
Net periodic benefit income	$	(61	)	$	(15	)	$	(122	)	$	(30	)

For the three and six months ended December 31, 2013, we made no pension plan contributions and we expect to make no contributions to our pension plans during 2014.

Note 8 – Postretirement Benefits

We and certain of our operating subsidiaries provide multiple postretirement medical and life insurance benefit plans. We recognize the cost of benefits as the employees render service. Postretirement benefits are funded as incurred.

The following table summarizes the components of net periodic benefit cost for our postretirement plans:

	Three Months Ended   December 31,						Six Months Ended   December 31,
	2013			2012			2013			2012
Components of net periodic benefit cost
Service cost	$	8		$	8		$	16		$	16
Interest cost	32			28			64			56
Amortization of unrecognized net gain	(7		)	(5		)	(14		)	(10		)
Amortization of prior service asset	(1		)	(1		)	(2		)	(2		)
Net periodic benefit cost	$	32		$	30		$	64		$	60

13

LANCASTER COLONY CORPORATION AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Tabular amounts in thousands, except per share data)

For the three and six months ended December 31, 2013, we made approximately $40,000 and $65,000 in contributions to our postretirement medical and life insurance benefit plans. We expect to make approximately $0.1 million more in contributions to our postretirement medical and life insurance benefit plans during the remainder of 2014.

Note 9 – Commitments and Contingencies

At December 31, 2013, we were a party to various claims and litigation matters arising in the ordinary course of business. Such matters did not have a material effect on the current-year results of operations and, in our opinion, their ultimate disposition will not have a material effect on our consolidated financial statements.

The Continued Dumping and Subsidy Offset Act of 2000 (“CDSOA”) provides for the distribution of monies collected by U.S. Customs from anti-dumping cases to qualifying domestic producers. Our CDSOA receipts totaled approximately $0.1 million in the second quarter of 2014, as compared to approximately $0.3 million in the second quarter of 2013.

As of January 30, 2014, we sold substantially all of the net operating assets of our candle manufacturing and marketing operations to an unaffiliated buyer. While we retained the right to seek further CDSOA remittances relating to past periods, we are currently unaware of any funds made available to manufacturers who may have otherwise qualified for CDSOA remittances but have exited the applicable business. Accordingly, we cannot predict the amount of future distributions, if any, we may receive. U.S. Customs has advised affected domestic producers that it is possible that CDSOA distributions which we received could be subject to clawback until the resolution of outstanding litigation. We believe that the likelihood of clawback is remote. Any change in CDSOA distributions could affect our earnings and cash flow.

Note 10 – Business Segments Information

The following summary of financial information by business segment is consistent with the basis of segmentation and measurement of segment profit or loss presented in our June 30, 2013 consolidated financial statements. The December 31, 2013 identifiable assets by reportable segment are generally consistent with that of June 30, 2013.

	Three Months Ended   December 31,						Six Months Ended   December 31,
	2013			2012			2013			2012
Net Sales
Specialty Foods	$	292,281		$	272,634		$	540,418		$	521,515
Glassware and Candles	43,269			53,521			80,988			95,616
Total	$	335,550		$	326,155		$	621,406		$	617,131
Operating Income
Specialty Foods	$	59,413		$	50,384		$	98,956		$	93,142
Glassware and Candles	3,186			5,614			4,355			6,222
Corporate Expenses	(3,228		)	(3,373		)	(6,340		)	(6,167		)
Total	$	59,371		$	52,625		$	96,971		$	93,197

As a result of the sale of assets noted in the Subsequent Events disclosure within Note 1, the Glassware and Candles segment will be presented as discontinued operations in future financial presentations.    

14

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

LANCASTER COLONY CORPORATION AND SUBSIDIARIES

MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION

AND RESULTS OF OPERATIONS

Our fiscal year begins on July 1 and ends on June 30. Unless otherwise noted, references to “year” pertain to our fiscal year; for example, 2014 refers to fiscal 2014, which is the period from July 1, 2013 to June 30, 2014.

The following discussion should be read in conjunction with our condensed consolidated financial statements and the notes thereto, all included elsewhere in this report. The forward-looking statements in this section and other parts of this report involve risks, uncertainties and other factors, including statements regarding our plans, objectives, goals, strategies, and financial performance. Our actual results could differ materially from the results anticipated in these forward-looking statements due to these factors. For more information, see the section below entitled “Forward-Looking Statements.”

OVERVIEW

Business Overview

Lancaster Colony Corporation is a manufacturer and marketer of specialty food products for the retail and foodservice markets.

In recent years, our strategy has shifted away from operating businesses in a variety of industries towards emphasizing the growth and success we have achieved in our Specialty Foods segment. Consistent with this strategy, on January 30, 2014, we sold effectively all of the net operating assets of our candle manufacturing and marketing operations for approximately $28 million in cash, subject to customary post-closing adjustments. Net proceeds from the sale, as subject to the customary post-closing adjustments, are expected to total approximately $27 million, exclusive of the tax benefit anticipated to be realized from the loss incurred. The transaction is expected to result in a pretax loss of approximately $43 to $45 million, which will be recorded in the quarter ended March 31, 2014. The financial results of these divested operations will be reported as discontinued operations for all periods presented in future financial filings.

Prior to the divestiture noted above, our operations were organized in two reportable segments: “Specialty Foods” and “Glassware and Candles.” With the completion of the sale, our business operations are now exclusive to the manufacturing and marketing of specialty food products. Our sales are predominately domestic.

We view our food operations as having the potential to achieve future growth in sales and profitability due to attributes such as:

• leading retail market positions in several branded products with a high-quality perception;

• a broad customer base in both retail and foodservice accounts;

• well-regarded culinary expertise among foodservice accounts;

• recognized leadership in foodservice product development;

• experience in integrating complementary business acquisitions; and

• historically strong cash flow generation that supports growth opportunities.

The objective of our food operations is to grow both retail and foodservice sales over time by:

• leveraging the strength of our retail brands to increase current product sales, introduce new products and expand to new channels;

• growing our foodservice sales through the strength of our reputation in product development and quality; and

• pursuing acquisitions that meet our strategic criteria.

We have made substantial capital investments to support our existing food operations and future growth opportunities. Based on our current plans and expectations, we believe that our total capital expenditures for 2014 could total approximately $15 million, depending on the timing and approval of certain projects currently being evaluated.

Summary of 2014 Results

The following is a comparative overview of our consolidated operating results for the three and six months ended December 31, 2013 and 2012.

Net sales for the three months ended December 31, 2013increased 3% to approximately $335.6 million from the prior-year total of $326.2 million. This sales increase reflects higher sales in the Specialty Foods segment due to higher retail and

15

foodservice volumes. Glassware and Candles net sales declined as a result of lower sales of seasonal products and more challenging retail conditions. The second quarter gross margin increased 8% to approximately $88.3 million from the prior-year total of $81.7 million. The higher level of net sales and a moderate decline in raw-material costs in the Specialty Foods segment contributed to the higher gross margin. Net income for the three months ended December 31, 2013 totaled approximately $39.2 million, or $1.44 per diluted share. Net income totaled approximately $35.3 million in the second quarter of the prior year, or $1.28 per diluted share.

Year-to-date net sales for the period ended December 31, 2013increased 1% to approximately $621.4 million from the prior-year total of $617.1 million. Gross margin increased 2% to approximately $149.9 million from the prior year-to-date total of $147.4 million. Net income for the six months ended December 31, 2013 totaled approximately $64.0 million, or $2.34 per diluted share. Net income totaled approximately $61.9 million in the six months ended December 31, 2012, or $2.26 per diluted share.

RESULTS OF CONSOLIDATED OPERATIONS

Net Sales and Gross Margin

	Three Months Ended   December 31,											Six Months Ended   December 31,
(Dollars in thousands)	2013			2012			Change					2013			2012			Change
Net Sales
Specialty Foods	$	292,281		$	272,634		$	19,647		7	%	$	540,418		$	521,515		$	18,903		4	%
Glassware and Candles	43,269			53,521			(10,252		)	(19	)%	80,988			95,616			(14,628		)	(15	)%
Total	$	335,550		$	326,155		$	9,395		3	%	$	621,406		$	617,131		$	4,275		1	%
Gross Margin	$	88,308		$	81,656		$	6,652		8	%	$	149,946		$	147,373		$	2,573		2	%
Gross Margin as a Percentage of Net Sales	26.3		%	25.0		%						24.1		%	23.9		%

Consolidated net sales for the second quarter and six months ended December 31, 2013increased 3% and 1%, respectively. For both of these periods, higher sales within the Specialty Foods segment were partially offset by lower sales within the Glassware and Candles segment.

For the three and six months ended December 31, 2013, net sales of the Specialty Foods segment increased by 7% and 4%, respectively. Net sales of both retail and foodservice products improved during each comparative period. Retail sales growth in the quarter was influenced by the success of recently introduced products, broadly improved sales of frozen products and generally comparable levels of trade and consumer promotions. Foodservice sales improved primarily due to higher volume, especially to larger chain restaurants, and in spite of lower pricing totaling less than one percent of segment net sales for both the quarter and six-month periods. The segment's sales volume is estimated to have improved by approximately 6% and 4% for the three and six months ended December 31, 2013, respectively.

Net sales of the Glassware and Candles segment for the three and six months ended December 31, 2013decreased by 19% and 15%, respectively, on lower sales of seasonal products and challenging retail conditions.

As a percentage of net sales, our consolidated gross margin for the three and six months ended December 31, 2013 was 26.3% and 24.1%, respectively, as compared to 25.0% and 23.9% achieved in the prior-year comparative periods.

In the Specialty Foods segment, gross margin percentages improved slightly for both the three and six months ended December 31, 2013, reflecting factors such as modestly lower raw-material costs and benefits from higher sales volumes and a more favorable sales mix. We estimate that lower material costs beneficially affected the segment's gross margins by approximately one percent of segment nets sales for both the three and six months ended December 31, 2013. Looking forward, under current market conditions, we foresee modestly favorable material-cost comparisons over the balance of fiscal 2014.

Gross margin percentages in the Glassware and Candles segment decreased for both the three and six months ended December 31, 2013 due to lower sales and production volumes despite an improved sales mix.

16

Selling, General and Administrative Expenses

	Three Months Ended   December 31,											Six Months Ended   December 31,
(Dollars in thousands)	2013			2012			Change					2013			2012			Change
SG&A Expenses	$	28,937		$	29,031		$	(94	)	—	%	$	52,975		$	54,176		$	(1,201	)	(2	)%
SG&A Expenses as a Percentage of Net Sales	8.6		%	8.9		%						8.5		%	8.8		%

Consolidated selling, general and administrative costs totaled approximately $28.9 million and $53.0 million for the three and six months ended December 31, 2013, respectively, compared to the $29.0 million and $54.2 million incurred for the three and six months ended December 31, 2012. These costs were generally comparable as a percentage of net sales compared to the same periods in the prior year.

Operating Income

The foregoing factors contributed to consolidated operating income totaling approximately $59.4 million and $97.0 million for the three and six months ended December 31, 2013, respectively. By segment, our operating income can be summarized as follows:

	Three Months Ended   December 31,											Six Months Ended   December 31,
(Dollars in thousands)	2013			2012			Change					2013			2012			Change
Operating Income
Specialty Foods	$	59,413		$	50,384		$	9,029		18	%	$	98,956		$	93,142		$	5,814		6	%
Glassware and Candles	3,186			5,614			(2,428		)	(43	)%	4,355			6,222			(1,867		)	(30	)%
Corporate Expenses	(3,228		)	(3,373		)	145			(4	)%	(6,340		)	(6,167		)	(173		)	3	%
Total	$	59,371		$	52,625		$	6,746		13	%	$	96,971		$	93,197		$	3,774		4	%
Operating Income as a Percentage of Net Sales
Specialty Foods	20.3		%	18.5		%						18.3		%	17.9		%
Glassware and Candles	7.4		%	10.5		%						5.4		%	6.5		%
Total	17.7		%	16.1		%						15.6		%	15.1		%

Other Income - Continued Dumping and Subsidy Offset Act

The Continued Dumping and Subsidy Offset Act of 2000 (“CDSOA”) provides for the distribution of monies collected by U.S. Customs from anti-dumping cases to qualifying domestic producers. Our CDSOA receipts totaled approximately $0.1 million in the second quarter of 2014, as compared to approximately $0.3 million in the second quarter of 2013.

As of January 30, 2014, we sold substantially all of the net operating assets of our candle manufacturing and marketing operations to an unaffiliated buyer. While we retained the right to seek further CDSOA remittances relating to past periods, we are currently unaware of any funds made available to manufacturers who may have otherwise qualified for CDSOA remittances but have exited the applicable business. Accordingly, we cannot predict the amount of future distributions, if any, we may receive. U.S. Customs has advised affected domestic producers that it is possible that CDSOA distributions which we received could be subject to clawback until the resolution of outstanding litigation. We believe that the likelihood of clawback is remote. Any change in CDSOA distributions could affect our earnings and cash flow.

Interest Income and Other – Net

Interest income and other was expense of approximately $0.1 million and $0.2 million for the three and six months ended December 31, 2013, respectively, as compared to expense of less than $0.1 million for the three and six months ended December 31, 2012.

17

Income Before Income Taxes

As impacted by the factors discussed above, income before income taxes for the three months ended December 31, 2013increased by approximately $6.4 million to $59.3 million from the prior-year total of $52.9 million. Income before income taxes for the six months ended December 31, 2013 and 2012 was approximately $96.9 million and $93.5 million, respectively. Our effective tax rate of 33.9% for the six months ended December 31, 2013 was comparable to the prior-year rate of 33.7%.

Net Income

Second quarter net income for 2014 of approximately $39.2 millionincreased from the preceding year’s net income for the quarter of $35.3 million, as influenced by the factors noted above. Year-to-date net income of approximately $64.0 million was higher than the prior year-to-date total of $61.9 million. Net income per share for the second quarter of 2014 totaled $1.44 per basic and diluted share, as compared to $1.29 and $1.28 per basic and diluted share, respectively, in the prior year. Year-to-date net income per share was $2.35 and $2.34 per basic and diluted share, respectively, as compared to $2.26 per basic and diluted share for the prior-year period.

FINANCIAL CONDITION

For the six months ended December 31, 2013, net cash provided by operating activities totaled approximately $84.1 million as compared to $67.8 million in the prior-year period. Although influenced by the higher level of net income, the increase primarily resulted from the relative changes in working capital, particularly inventory and prepaid expenses. The increase in receivables since June 2013 primarily related to seasonal influences on sales within the Glassware and Candles segment but was also impacted by higher sales in the Specialty Foods segment.

Cash used in investing activities for the six months ended December 31, 2013 was approximately $5.0 million as compared to $10.6 million in the prior year. This decrease reflected a lower level of capital expenditures in 2014.

Cash used in financing activities for the six months ended December 31, 2013 of approximately $26.2 milliondecreased from the prior-year total of $156.3 million. This decrease was primarily due to lower dividend payments in the current year. Prior-year dividend payments included a $5.00 per share special dividend that was paid in December 2012. The special dividend payment totaled in excess of $136 million. The lower dividend payments were partially offset by a higher level of share repurchases in the current year. At December 31, 2013, approximately 1,428,000 shares remained authorized for future buyback under the existing share repurchase program.

Under our unsecured revolving credit facility, we may borrow up to a maximum of $120 million at any one time. Loans may be used for general corporate purposes. We had no borrowings outstanding under this facility at December 31, 2013. At December 31, 2013, we had approximately $3.7 million of standby letters of credit outstanding, which reduced the amount available for borrowing on the unsecured revolving credit facility. The facility expires in April 2017, and all outstanding amounts are then due and payable. Interest is variable based upon formulas tied to LIBOR or an alternative base rate defined in the credit agreement, at our option. We must also pay facility fees that are tied to our then-applicable consolidated leverage ratio. Based on the long-term nature of this facility, when we have outstanding borrowings under this facility, we will classify the outstanding balance as long-term debt.

The facility contains certain restrictive covenants, including limitations on indebtedness, asset sales and acquisitions, and financial covenants relating to interest coverage and leverage. At December 31, 2013, we were in compliance with all applicable provisions and covenants of the facility, and we exceeded the requirements of the financial covenants by substantial margins.

We currently expect to remain in compliance with the facility’s covenants for the foreseeable future. A default under the facility could accelerate the repayment of any outstanding indebtedness and limit our access to additional credit available under the facility. Such an event could require curtailment of cash dividends or share repurchases, reduce or delay beneficial expansion or investment plans, or otherwise impact our ability to meet our obligations when due. At December 31, 2013, we were not aware of any event that would constitute a default under the facility.

We believe that internally generated funds and our existing balances in cash and equivalents, in addition to our currently available bank credit arrangements, should be adequate to meet our cash requirements through 2014. If we were to borrow outside of our credit facility under current market terms, our average interest rate may increase significantly and have an adverse effect on our results of operations.

For additional information regarding our credit facility, see Note 4 to the condensed consolidated financial statements.

18

CONTRACTUAL OBLIGATIONS

We have various contractual obligations that are appropriately recorded as liabilities in our condensed consolidated financial statements. Certain other items, such as purchase obligations, are not recognized as liabilities in our condensed consolidated financial statements. Examples of items not recognized as liabilities in our condensed consolidated financial statements are commitments to purchase raw materials or inventory that has not yet been received as of December 31, 2013 and future minimum lease payments for the use of property and equipment under operating lease agreements. Aside from expected changes in raw-material needs due to changes in product demand, there have been no significant changes to the contractual obligations disclosed in our 2013 Annual Report on Form 10-K.

CRITICAL ACCOUNTING POLICIES

There have been no changes in critical accounting policies from those disclosed in our 2013 Annual Report on Form 10-K.

RECENTLY ISSUED ACCOUNTING STANDARDS

There were no recently issued accounting pronouncements that impact our consolidated financial statements.

RECENTLY ADOPTED ACCOUNTING STANDARDS

In February 2013, the Financial Accounting Standards Board issued Accounting Standards Update (“ASU”) No. 2013-02, “Comprehensive Income: Reporting of Amounts Reclassified Out of Accumulated Other Comprehensive Income” (“ASU 13-02”) which added new disclosure requirements for items reclassified out of accumulated other comprehensive income. ASU 13-02 effectively replaced the requirements outlined in previous ASUs. The requirements of ASU 13-02 were effective for fiscal years, and interim periods within those years, beginning after December 15, 2012. We adopted this guidance in the quarter ended September 30, 2013. The adoption did not have an impact on our financial position, results of operations or cash flows because it related to disclosures only.

FORWARD-LOOKING STATEMENTS

We desire to take advantage of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995 (the “PSLRA”). This Quarterly Report on Form 10-Q contains various “forward-looking statements” within the meaning of the PSLRA and other applicable securities laws. Such statements can be identified by the use of the forward-looking words “anticipate,” “estimate,” “project,” “believe,” “intend,” “plan,” “expect,” “hope” or similar words. These statements discuss future expectations; contain projections regarding future developments, operations or financial conditions; or state other forward-looking information. Such statements are based upon assumptions and assessments made by us in light of our experience and perception of historical trends, current conditions, expected future developments and other factors we believe to be appropriate. These forward-looking statements involve various important risks, uncertainties and other factors that could cause our actual results to differ materially from those expressed in the forward-looking statements. Actual results may differ as a result of factors over which we have no, or limited, control including, without limitation, the specific influences outlined below. Management believes these forward-looking statements to be reasonable; however, you should not place undue reliance on such statements that are based on current expectations. Forward-looking statements speak only as of the date they are made, and we undertake no obligation to update such forward-looking statements, except as required by law.

Items which could impact these forward-looking statements include, but are not limited to:

• the potential for loss of larger programs or key customer relationships;

• the effect of consolidation of customers within key market channels;

• the success and cost of new product development efforts;

• the lack of market acceptance of new products;

• the reaction of customers or consumers to the effect of price increases we may implement;

• changes in demand for our products, which may result from loss of brand reputation or customer goodwill;

• the extent to which future business acquisitions are completed and acceptably integrated;

• the possible occurrence of product recalls or other defective or mislabeled product costs;

• efficiencies in plant operations;

• price and product competition;

19

• the uncertainty regarding the effect of the sale of our candle manufacturing and marketing operation;

• fluctuations in the cost and availability of raw materials;

• adverse changes in energy costs and other factors that may affect costs of producing, distributing or transporting our products;

• the impact of fluctuations in our pension plan asset values on funding levels, contributions required and benefit costs;

• maintenance of competitive position with respect to other manufacturers, including global sources of production;

• dependence on key personnel;

• stability of labor relations;

• dependence on contract copackers and limited or exclusive sources for certain goods;

• legislation and litigation affecting the future administration of the Continued Dumping and Subsidy Offset Act of 2000;

• access to any required financing;

• changes in estimates in critical accounting judgments;

• the outcome of any litigation or arbitration; and

• certain other factors, including the information disclosed in our discussion of risk factors under Item 1A of our 2013 Annual Report on Form 10-K.

Item 3. Quantitative and Qualitative Disclosures About Market Risk

Our market risks have not changed materially from those disclosed in our 2013 Annual Report on Form 10-K.

Item 4. Controls and Procedures

(a) Evaluation of Disclosure Controls and Procedures. As of the end of the period covered by this Quarterly Report on Form 10-Q, our Chief Executive Officer and Chief Financial Officer evaluated, with the participation of management, the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)). Based upon this evaluation, our Chief Executive Officer and Chief Financial Officer have concluded that our disclosure controls and procedures were effective as of December 31, 2013 to ensure that information required to be disclosed in the reports that we file or submit under the Exchange Act is 1) recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms and 2) accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, in a manner that allows timely decisions regarding required disclosure.

(b) Changes in Internal Control Over Financial Reporting. No changes were made to our internal control over financial reporting (as such term is defined in Rules 13a-15(f) and 15d-15(f) of the Exchange Act) during our most recent fiscal quarter that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

20

PART II – OTHER INFORMATION

Item 1A. Risk Factors

There have been no material changes to the risk factors disclosed under Item 1A in our 2013 Annual Report on Form 10-K.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

(c) In November 2010, our Board of Directors approved a share repurchase authorization of 2,000,000 shares, of which approximately 1,428,000 shares remained authorized for future repurchases at December 31, 2013. This share repurchase authorization does not have a stated expiration date. In the second quarter, we made no repurchases of our common stock.

Period	Total Number of Shares Purchased	Average Price Paid Per Share		Total Number of Shares Purchased as Part of Publicly Announced Plans	Maximum Number of Shares that May Yet be Purchased Under the Plans
October 1-31, 2013	—	$	—	—	1,427,776
November 1-30, 2013	—	$	—	—	1,427,776
December 1-31, 2013	—	$	—	—	1,427,776
Total	—	$	—	—	1,427,776

Item 6. Exhibits

See Index to Exhibits following Signatures.

21

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

		LANCASTER COLONY CORPORATION
			(Registrant)
Date:	February 10, 2014	By:	/s/ JOHN B. GERLACH, JR.
			John B. Gerlach, Jr.
			Chairman, Chief Executive Officer,
			President and Director
			(Principal Executive Officer)
Date:	February 10, 2014	By:	/s/ JOHN L. BOYLAN
			John L. Boylan
			Treasurer, Vice President,
			Assistant Secretary,
			Chief Financial Officer
			and Director
			(Principal Financial and Accounting Officer)

22

LANCASTER COLONY CORPORATION AND SUBSIDIARIES

FORM 10-Q

DECEMBER 31, 2013

INDEX TO EXHIBITS

Exhibit Number	Description	Located at
31.1	Certification of CEO under Section 302 of the Sarbanes-Oxley Act of 2002	Filed herewith
31.2	Certification of CFO under Section 302 of the Sarbanes-Oxley Act of 2002	Filed herewith
32	Certification of CEO and CFO under Section 906 of the Sarbanes-Oxley Act of 2002	Filed herewith
101.INS	XBRL Instance Document	Filed herewith
101.SCH	XBRL Taxonomy Extension Schema Document	Filed herewith
101.CAL	XBRL Taxonomy Extension Calculation Linkbase Document	Filed herewith
101.DEF	XBRL Taxonomy Extension Definition Linkbase Document	Filed herewith
101.LAB	XBRL Taxonomy Extension Label Linkbase Document	Filed herewith
101.PRE	XBRL Taxonomy Extension Presentation Linkbase Document	Filed herewith

23

EX-31.1

Exhibit 31.1

Certification by Chief Executive Officer

I, John B. Gerlach, Jr., certify that:

1. I have reviewed this quarterly report on Form 10-Q of Lancaster Colony Corporation;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date:	February 10, 2014	By:	/s/ JOHN B. GERLACH, JR.
			John B. Gerlach, Jr. Chief Executive Officer

EX-31.2

Exhibit 31.2

Certification by Chief Financial Officer

I, John L. Boylan, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Lancaster Colony Corporation;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date:	February 10, 2014	By:	/s/ JOHN L. BOYLAN
			John L. Boylan
			Chief Financial Officer

EX-32

Exhibit 32

CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER

PURSUANT TO 18, UNITED STATES CODE, SECTION 1350,

AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Lancaster Colony Corporation (the “Company”) on Form 10-Q for the quarter ending December 31, 2013, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), John B. Gerlach, Jr., Chief Executive Officer of the Company, and John L. Boylan, Chief Financial Officer of the Company, respectively, do each hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 that:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

By:	/s/ JOHN B. GERLACH, JR.
	John B. Gerlach, Jr.
	Chief Executive Officer
February 10, 2014
By:	/s/ JOHN L. BOYLAN
	John L. Boylan
	Chief Financial Officer
February 10, 2014

XML

Stock-Based Compensation (Schedule of Restricted Stock Granted To Nonemployee Directors) (Details) (Director Restricted Stock [Member], USD $) In Thousands, except Share data, unless otherwise specified	6 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Director Restricted Stock [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Restricted stock granted (in shares)	6,000	7,000
Grant date fair value	$ 490	$ 490
Weighted average grant date fair value per award	$ 84.42	$ 73.29

XML

Business Segments Information (Details) (USD $) In Thousands, unless otherwise specified	3 Months Ended		6 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2013	Dec. 31, 2012
Business Segment Information [Line Items]
Net Sales	$ 335,550	$ 326,155	$ 621,406	$ 617,131
Operating Income	59,371	52,625	96,971	93,197
Specialty Foods [Member]
Business Segment Information [Line Items]
Net Sales	292,281	272,634	540,418	521,515
Operating Income	59,413	50,384	98,956	93,142
Glassware And Candles [Member]
Business Segment Information [Line Items]
Net Sales	43,269	53,521	80,988	95,616
Operating Income	3,186	5,614	4,355	6,222
Corporate Expenses [Member]
Business Segment Information [Line Items]
Operating Income	$ (3,228)	$ (3,373)	$ (6,340)	$ (6,167)

XML

Postretirement Benefits (Components Of Net Periodic Benefit Cost) (Details) (Postretirement Benefits [Member], USD $) In Thousands, unless otherwise specified	3 Months Ended				6 Months Ended
	Dec. 31, 2013		Dec. 31, 2012		Dec. 31, 2013		Dec. 31, 2012
Postretirement Benefits [Member]
Defined Benefit Plan Disclosure [Line Items]
Service cost	$ 8		$ 8		$ 16		$ 16
Interest cost	32		28		64		56
Amortization of unrecognized net (gain) loss	(7)	[1]	(5)	[1]	(14)	[1]	(10)	[1]
Amortization of prior service asset	(1)	[1]	(1)	[1]	(2)	[1]	(2)	[1]
Net periodic benefit (income) cost	$ 32		$ 30		$ 64		$ 60

[1] Included in the computation of net periodic benefit income/cost. See Notes 7 and 8 for additional information.

XML

Long-Term Debt (Details) (USD $)	3 Months Ended		6 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2013	Dec. 31, 2012	Jun. 30, 2013
Debt Disclosure [Abstract]
Maximum borrowing capacity	$ 120,000,000		$ 120,000,000		$ 120,000,000
Maximum borrowing capacity on obtaining consent of the issuing bank	200,000,000		200,000,000		200,000,000
Line of credit facility, expiration date			Apr. 18, 2017
Line of credit facility, amount outstanding	0		0		0
Standby letters of credit, amount outstanding	3,700,000		3,700,000
Interest paid	$ 0	$ 0	$ 0	$ 0
Minimum interest coverage ratio			250.00%
Maximum leverage ratio			300.00%

XML

Summary Of Significant Accounting Policies (Schedule Of Assets And Liabilities Of Sold Operations) (Details) (USD $) In Thousands, unless otherwise specified	Dec. 31, 2013	Jun. 30, 2013
Accounting Policies [Abstract]
Cash	$ 1	$ 1
Receivables	26,594	14,061
Inventory	30,974	41,342
Other current assets	422	573
Property, plant and equipment	20,996	21,621
Other noncurrent assets	1,157	980
Total Assets	80,144	78,578
Accounts payable	4,029	5,431
Accrued liabilities	2,900	2,685
Total Liabilities	$ 6,929	$ 8,116

XML

Stock-Based Compensation (Restricted Stock Activity) (Details) (Restricted Stock [Member], USD $)	6 Months Ended
	Dec. 31, 2013
Restricted Stock [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]
Number of Shares, Unvested restricted stock at beginning of period	45,000
Number of Shares, Granted	6,000
Number of Shares, Vested	(7,000)
Number of Shares, Forfeited	0
Number of Shares, Unvested restricted stock at end of period	44,000
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Roll Forward]
Weighted Average Grant Date Fair Value, Unvested restricted stock at beginning of period	$ 68.16
Weighted Average Grant Date Fair Value, Granted	$ 84.27
Weighted Average Grant Date Fair Value, Vested	$ 72.94
Weighted Average Grant Date Fair Value, Forfeited	$ 0.00
Weighted Average Grant Date Fair Value, Unvested restricted stock at end of period	$ 69.61

XML

Stock-Based Compensation (Stock-Settled Stock Appreciation Rights Compensation Expense And Tax Benefits Recorded) (Details) (USD $) In Thousands, unless otherwise specified	3 Months Ended		6 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2013	Dec. 31, 2012
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Compensation expense			$ 1,200	$ 1,623
Gross windfall tax benefits			39	459
Stock Settled Stock Appreciation Rights SARS [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Compensation expense	212	338	519	799
Tax benefits	75	118	182	279
Intrinsic value of exercises	70	594	88	1,284
Gross windfall tax benefits	$ 25	$ 208	$ 31	$ 449

XML

Commitments And Contingencies (Details) (USD $) In Thousands, unless otherwise specified	3 Months Ended		6 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2013	Dec. 31, 2012
Commitments and Contingencies Disclosure [Abstract]
CDSOA receipts	$ 91	$ 293	$ 91	$ 293

XML

Goodwill And Other Intangible Assets

6 Months Ended

Dec. 31, 2013

Goodwill and Intangible Assets Disclosure [Abstract]

Goodwill And Other Intangible Assets

Goodwill and Other Intangible Assets

Goodwill attributable to the Specialty Foods segment was approximately $89.8 million at December 31, 2013 and June 30, 2013.

The following table summarizes our identifiable other intangible assets, all included in the Specialty Foods segment:

	December 31,   2013			June 30,   2013
Trademarks (40-year life)
Gross carrying value	$	370		$	370
Accumulated amortization	(209		)	(205		)
Net carrying value	$	161		$	165
Customer Relationships (12 to 15-year life)
Gross carrying value	$	13,020		$	13,020
Accumulated amortization	(7,332		)	(6,863		)
Net carrying value	$	5,688		$	6,157
Total net carrying value	$	5,849		$	6,322

Amortization expense for our intangible assets was as follows:

	Three Months Ended   December 31,				Six Months Ended   December 31,
	2013		2012		2013		2012
Amortization expense	$	237	$	236	$	473	$	472

Total annual amortization expense for each of the next five years is estimated to be as follows:

2015	$	946
2016	$	775
2017	$	604
2018	$	604
2019	$	604

XML

Pension Benefits (Narrative) (Details) (Pension Benefits [Member], USD $)	3 Months Ended	6 Months Ended
	Dec. 31, 2013	Dec. 31, 2013
Pension Benefits [Member]
Defined Benefit Plan Disclosure [Line Items]
Employer contributions	$ 0	$ 0
Estimated future employer contributions in current fiscal year		$ 0

XML

Goodwill And Other Intangible Assets (Narrative) (Details) (USD $) In Thousands, unless otherwise specified	Dec. 31, 2013	Jun. 30, 2013
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill	$ 89,840	$ 89,840

XML

Summary of Significant Accounting Policies (Reclassifications Out of Accumulated Other Comprehensive Loss) (Details) (USD $) In Thousands, unless otherwise specified	3 Months Ended				6 Months Ended
	Dec. 31, 2013		Dec. 31, 2012		Dec. 31, 2013		Dec. 31, 2012
Defined Benefit Plan Disclosure [Line Items]
Accumulated other comprehensive loss at beginning of period	$ (8,324)		$ (12,058)		$ (8,391)		$ (12,162)
Total other comprehensive income, before tax	107		166		214		332
Total tax expense	(39)		(62)		(79)		(124)
Other comprehensive income, net of tax	68		104		135		208
Accumulated other comprehensive loss at end of period	(8,256)		(11,954)		(8,256)		(11,954)
Pension Benefits [Member]
Defined Benefit Plan Disclosure [Line Items]
Amortization of unrecognized net (gain) loss	115	[1]	172	[1]	230	[1]	344	[1]
Postretirement Benefits [Member]
Defined Benefit Plan Disclosure [Line Items]
Amortization of unrecognized net (gain) loss	(7)	[1]	(5)	[1]	(14)	[1]	(10)	[1]
Amortization of prior service asset	$ (1)	[1]	$ (1)	[1]	$ (2)	[1]	$ (2)	[1]

[1] Included in the computation of net periodic benefit income/cost. See Notes 7 and 8 for additional information.

XML

Pension Benefits (Components Of Net Periodic Benefit Income) (Details) (Pension Benefits [Member], USD $) In Thousands, unless otherwise specified	3 Months Ended				6 Months Ended
	Dec. 31, 2013		Dec. 31, 2012		Dec. 31, 2013		Dec. 31, 2012
Pension Benefits [Member]
Defined Benefit Plan Disclosure [Line Items]
Interest cost	$ 438		$ 408		$ 876		$ 816
Expected return on plan assets	(614)		(595)		(1,228)		(1,190)
Amortization of unrecognized net loss	115	[1]	172	[1]	230	[1]	344	[1]
Net periodic benefit (income) cost	$ (61)		$ (15)		$ (122)		$ (30)

[1] Included in the computation of net periodic benefit income/cost. See Notes 7 and 8 for additional information.

XML

Goodwill And Other Intangible Assets (Summary Of Intangible Assets) (Details) (USD $) In Thousands, unless otherwise specified	6 Months Ended
	Dec. 31, 2013	Jun. 30, 2013
Finite-Lived Intangible Assets [Line Items]
Net carrying value	$ 5,849	$ 6,322
Trademarks (40-Year Life) [Member]
Finite-Lived Intangible Assets [Line Items]
Gross carrying value	370	370
Accumulated amortization	(209)	(205)
Net carrying value	161	165
Finite-lived intangible assets useful life	40 years
Customer Relationships (12 To 15-Year Life) [Member]
Finite-Lived Intangible Assets [Line Items]
Gross carrying value	13,020	13,020
Accumulated amortization	(7,332)	(6,863)
Net carrying value	$ 5,688	$ 6,157
Minimum [Member] | Customer Relationships (12 To 15-Year Life) [Member]
Finite-Lived Intangible Assets [Line Items]
Finite-lived intangible assets useful life	12 years
Maximum [Member] | Customer Relationships (12 To 15-Year Life) [Member]
Finite-Lived Intangible Assets [Line Items]
Finite-lived intangible assets useful life	15 years

XML

Goodwill And Other Intangible Assets (Schedule Of Amortization Expense) (Details) (USD $) In Thousands, unless otherwise specified	3 Months Ended		6 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2013	Dec. 31, 2012
Goodwill and Intangible Assets Disclosure [Abstract]
Amortization expense	$ 237	$ 236	$ 473	$ 472

XML

Impact Of Recently Issued Accounting Standards

6 Months Ended

Dec. 31, 2013

Accounting Changes and Error Corrections [Abstract]

Impact Of Recently Issued Accounting Standards

Impact of Recently Issued Accounting Standards

There were no recently issued accounting pronouncements that impact our consolidated financial statements.

XML

Goodwill And Other Intangible Assets (Estimated Annual Amortization Expense) (Details) (USD $) In Thousands, unless otherwise specified	Dec. 31, 2013
Goodwill and Intangible Assets Disclosure [Abstract]
2015	$ 946
2016	775
2017	604
2018	604
2019	$ 604

XML

Stock-Based Compensation (Summarized Restricted Stock Compensation Expense And Tax Benefits Recorded) (Details) (USD $) In Thousands, unless otherwise specified	3 Months Ended		6 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2013	Dec. 31, 2012
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Compensation expense			$ 1,200	$ 1,623
Gross windfall tax benefits			39	459
Restricted Stock [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Compensation expense	341	414	681	824
Tax benefits	120	144	239	288
Gross windfall tax benefits	$ 6	$ 9	$ 8	$ 10

XML

Condensed Consolidated Balance Sheets (USD $) In Thousands, unless otherwise specified	Dec. 31, 2013	Jun. 30, 2013
Current Assets:
Cash and equivalents	$ 176,263	$ 123,386
Receivables (less allowance for doubtful accounts, December-$1,021; June-$822)	86,862	70,398
Inventories:
Raw materials	30,973	35,012
Finished goods and work in process	61,567	74,139
Total inventories	92,540	109,151
Deferred income taxes and other current assets	17,208	23,123
Total current assets	372,873	326,058
Property, Plant and Equipment:
Land, buildings and improvements	144,784	144,206
Machinery and equipment	290,188	289,051
Total cost	434,972	433,257
Less accumulated depreciation	250,767	243,562
Property, plant and equipment-net	184,205	189,695
Other Assets:
Goodwill	89,840	89,840
Other intangible assets-net	5,849	6,322
Other noncurrent assets	7,921	8,049
Total	660,688	619,964
Current Liabilities:
Accounts payable	42,554	41,890
Accrued liabilities	35,498	35,287
Total current liabilities	78,052	77,177
Other Noncurrent Liabilities	23,175	23,291
Deferred Income Taxes	18,755	18,274
Shareholders' Equity:
Preferred stock-authorized 3,050,000 shares; outstanding-none
Common stock-authorized 75,000,000 shares; outstanding – December-27,290,849 shares; June-27,323,721 shares	103,826	102,622
Retained earnings	1,180,315	1,139,213
Accumulated other comprehensive loss	(8,256)	(8,391)
Common stock in treasury, at cost	(735,179)	(732,222)
Total shareholders' equity	540,706	501,222
Total	$ 660,688	$ 619,964

XML

Postretirement Benefits (Narrative) (Details) (Postretirement Benefits [Member], USD $)	3 Months Ended	6 Months Ended
	Dec. 31, 2013	Dec. 31, 2013
Postretirement Benefits [Member]
Defined Benefit Plan Disclosure [Line Items]
Employer contributions	$ 40,000	$ 65,000
Estimated future employer contributions in current fiscal year		$ 100,000

XML

Condensed Consolidated Statements Of Cash Flows (USD $) In Thousands, unless otherwise specified	6 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Cash Flows From Operating Activities:
Net income	$ 64,035	$ 61,939
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	10,649	9,971
Deferred income taxes and other noncash changes	672	(848)
Stock-based compensation expense	1,200	1,623
Gain on sale of property	(6)	(41)
Pension plan activity	(122)	(30)
Changes in operating assets and liabilities:
Receivables	(16,666)	(18,153)
Inventories	16,611	9,160
Other current assets	6,716	(1,385)
Accounts payable and accrued liabilities	983	5,515
Net cash provided by operating activities	84,072	67,751
Cash Flows From Investing Activities:
Payments on property additions	(4,370)	(10,359)
Proceeds from sale of property	6	148
Other-net	(656)	(359)
Net cash used in investing activities	(5,020)	(10,570)
Cash Flows From Financing Activities:
Purchase of treasury stock	(2,957)	0
Payment of dividends	(22,933)	(156,755)
Excess tax benefit from stock-based compensation	39	459
Decrease in cash overdraft balance	(324)	0
Net cash used in financing activities	(26,175)	(156,296)
Net change in cash and equivalents	52,877	(99,115)
Cash and equivalents at beginning of year	123,386	191,636
Cash and equivalents at end of period	176,263	92,521
Supplemental Disclosure of Operating Cash Flows:
Cash paid during the period for income taxes	$ 25,016	$ 32,043

XML

Stock-Based Compensation (Narrative) (Details) (USD $)	6 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Stock Settled Stock Appreciation Rights SARS [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period	3 years
Unrecognized compensation cost	$ 1,000,000
Weighted-average period over which remaining compensation cost will be recognized	1 year 7 months 21 days
Number vested	0	0
SSSARs granted (in rights)	2,000	0
Weighted average grant date fair value per award	$ 10.14
Restricted Stock [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized compensation cost	1,500,000
Weighted-average period over which remaining compensation cost will be recognized	1 year 4 months 2 days
Number vested	7,000
Restricted stock granted (in shares)	6,000
Weighted average grant date fair value per award	$ 84.27
Director Restricted Stock [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period	1 year
Restricted stock granted (in shares)	6,000	7,000
Grant date fair value	490,000	490,000
Weighted average grant date fair value per award	$ 84.42	$ 73.29
Number of nonemployee directors	7	7
Employee Restricted Stock [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period	3 years
Number vested	0	0
Restricted stock granted (in shares)	200	0
Grant date fair value	$ 16,000
Weighted average grant date fair value per award	$ 79.78
2005 Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Common shares reserved for issuance to qualified key employees	2,000,000
Maximum term of stock awards granted	5 years

XML

Postretirement Benefits (Tables) (Postretirement Benefits [Member])

6 Months Ended

Dec. 31, 2013

Postretirement Benefits [Member]

Defined Benefit Plan Disclosure [Line Items]

Components Of Net Periodic Benefit Cost

The following table summarizes the components of net periodic benefit cost for our postretirement plans:

	Three Months Ended   December 31,						Six Months Ended   December 31,
	2013			2012			2013			2012
Components of net periodic benefit cost
Service cost	$	8		$	8		$	16		$	16
Interest cost	32			28			64			56
Amortization of unrecognized net gain	(7		)	(5		)	(14		)	(10		)
Amortization of prior service asset	(1		)	(1		)	(2		)	(2		)
Net periodic benefit cost	$	32		$	30		$	64		$	60

XML

Stock-Based Compensation (Stock-Settled Stock Appreciation Rights Grant Details) (Details) (Stock Settled Stock Appreciation Rights SARS [Member], USD $)	6 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Stock Settled Stock Appreciation Rights SARS [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
SSSARs granted (in rights)	2,000	0
Weighted average grant date fair value per award	$ 10.14
Risk-free interest rate	0.61%
Dividend yield	2.01%
Volatility factor of the expected market price of our common stock	23.00%
Weighted average expected life in years	2 years 8 months 5 days
Estimated forfeiture rate	0.00%

XML

Summary Of Significant Accounting Policies (Narrative) (Details) (Subsequent Event [Member], USD $) In Millions, unless otherwise specified	0 Months Ended
	Jan. 30, 2014
Subsequent Event [Line Items]
Cash Proceeds From Sale of Candle Operations	$ 28
Estimated Net Proceeds From Sale Of Candle Operations	27
Minimum [Member]
Subsequent Event [Line Items]
Estimated Pretax Loss From Sale Of Candle Operations	43
Maximum [Member]
Subsequent Event [Line Items]
Estimated Pretax Loss From Sale Of Candle Operations	$ 45

XML

Summary Of Significant Accounting Policies

6 Months Ended

Dec. 31, 2013

Accounting Policies [Abstract]

Summary Of Significant Accounting Policies

Summary of Significant Accounting Policies

Basis of Presentation

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) for interim financial information and SEC Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. In our opinion, the interim condensed consolidated financial statements reflect all adjustments necessary for a fair presentation of the results of operations and financial position for such periods. All such adjustments reflected in the interim condensed consolidated financial statements are considered to be of a normal recurring nature. The results of operations for any interim period are not necessarily indicative of results for the full year. Accordingly, these financial statements should be read in conjunction with the financial statements and notes thereto contained in our 2013 Annual Report on Form 10-K. Unless otherwise noted, the term “year” and references to a particular year pertain to our fiscal year, which begins on July 1 and ends on June 30; for example, 2014 refers to fiscal 2014, which is the period from July 1, 2013 to June 30, 2014.

Subsequent Events

On January 30, 2014, we sold effectively all of the net operating assets of our candle manufacturing and marketing operations for approximately $28 million in cash, subject to customary post-closing adjustments. Net proceeds from the sale, as subject to the customary post-closing adjustments, are expected to total approximately $27 million, exclusive of the tax benefit anticipated to be realized from the loss incurred. The transaction is expected to result in a pretax loss of approximately $43 to $45 million, which will be recorded in the quarter ended March 31, 2014. See Note 10 for net sales and operating income information related to the Glassware and Candles segment.

The assets and liabilities of our sold operations were as follows:

	December 31,   2013		June 30,   2013
Cash	$	1	$	1
Receivables	26,594		14,061
Inventory	30,974		41,342
Other current assets	422		573
Property, plant and equipment	20,996		21,621
Other noncurrent assets	1,157		980
Total Assets	$	80,144	$	78,578
Accounts payable	$	4,029	$	5,431
Accrued liabilities	2,900		2,685
Total Liabilities	$	6,929	$	8,116

Property, Plant and Equipment

Property, plant and equipment are stated at cost less accumulated depreciation. Purchases of property, plant and equipment included in accounts payable and excluded from the property additions and the change in accounts payable in the Condensed Consolidated Statements of Cash Flows were as follows:

	December 31,
	2013		2012
Construction in progress in accounts payable	$	70	$	3,393

Earnings Per Share

Earnings per share (“EPS”) is computed based on the weighted average number of shares of common stock and common stock equivalents (restricted stock and stock-settled stock appreciation rights) outstanding during each period. Unvested shares of restricted stock granted to employees are considered participating securities since employees receive nonforfeitable dividends prior to vesting and, therefore, are included in the earnings allocation in computing EPS under the two-class method. Basic EPS excludes dilution and is computed by dividing income available to common shareholders by the weighted average number of common shares outstanding during the period. Diluted EPS is computed by dividing income available to common shareholders by the diluted weighted average number of common shares outstanding during the period, which includes the dilutive potential common shares associated with nonparticipating restricted stock and stock-settled stock appreciation rights.

Basic and diluted net income per common share were calculated as follows:

	Three Months Ended   December 31,						Six Months Ended   December 31,
	2013			2012			2013			2012
Net income	$	39,234		$	35,277		$	64,035		$	61,939
Net income available to participating securities	(53		)	(246		)	(87		)	(299		)
Net income available to common shareholders	$	39,181		$	35,031		$	63,948		$	61,640
Weighted average common shares outstanding – basic	27,244			27,243			27,256			27,236
Incremental share effect from:
Nonparticipating restricted stock	3			4			4			4
Stock-settled stock appreciation rights	52			26			46			28
Weighted average common shares outstanding – diluted	27,299			27,273			27,306			27,268
Net income per common share – basic	$	1.44		$	1.29		$	2.35		$	2.26
Net income per common share – diluted	$	1.44		$	1.28		$	2.34		$	2.26

Reclassifications Out of Accumulated Other Comprehensive Loss

The following table presents the amounts reclassified out of accumulated other comprehensive loss by component:

	Three Months Ended   December 31,						Six Months Ended   December 31,
	2013			2012			2013			2012
Accumulated other comprehensive loss at beginning of period	$	(8,324	)	$	(12,058	)	$	(8,391	)	$	(12,162	)
Defined Benefit Pension Plan Items:
Amortization of unrecognized net loss (1)	115			172			230			344
Postretirement Benefit Plan Items:
Amortization of unrecognized net gain (1)	(7		)	(5		)	(14		)	(10		)
Amortization of prior service asset (1)	(1		)	(1		)	(2		)	(2		)
Total other comprehensive income, before tax	107			166			214			332
Total tax expense	(39		)	(62		)	(79		)	(124		)
Other comprehensive income, net of tax	68			104			135			208
Accumulated other comprehensive loss at end of period	$	(8,256	)	$	(11,954	)	$	(8,256	)	$	(11,954	)

(1) Included in the computation of net periodic benefit income/cost. See Notes 7 and 8 for additional information.

Significant Accounting Policies

There were no changes to our Significant Accounting Policies from those disclosed in our 2013 Annual Report on Form 10-K.

XML

Condensed Consolidated Balance Sheets (Parenthetical) (USD $) In Thousands, except Share data, unless otherwise specified	Dec. 31, 2013	Jun. 30, 2013
Statement of Financial Position [Abstract]
Allowance for doubtful accounts	$ 1,021	$ 822
Preferred stock, shares authorized	3,050,000	3,050,000
Preferred stock, shares outstanding	0	0
Common stock, shares authorized	75,000,000	75,000,000
Common stock, shares outstanding	27,290,849	27,323,721

XML

Summary Of Significant Accounting Policies (Policy)

6 Months Ended

Dec. 31, 2013

Accounting Policies [Abstract]

Basis Of Presentation

Basis of Presentation

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) for interim financial information and SEC Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. In our opinion, the interim condensed consolidated financial statements reflect all adjustments necessary for a fair presentation of the results of operations and financial position for such periods. All such adjustments reflected in the interim condensed consolidated financial statements are considered to be of a normal recurring nature. The results of operations for any interim period are not necessarily indicative of results for the full year. Accordingly, these financial statements should be read in conjunction with the financial statements and notes thereto contained in our 2013 Annual Report on Form 10-K. Unless otherwise noted, the term “year” and references to a particular year pertain to our fiscal year, which begins on July 1 and ends on June 30; for example, 2014 refers to fiscal 2014, which is the period from July 1, 2013 to June 30, 2014.

Property, Plant And Equipment

Property, Plant and Equipment

Property, plant and equipment are stated at cost less accumulated depreciation.

Earnings Per Share

Earnings Per Share

Earnings per share (“EPS”) is computed based on the weighted average number of shares of common stock and common stock equivalents (restricted stock and stock-settled stock appreciation rights) outstanding during each period. Unvested shares of restricted stock granted to employees are considered participating securities since employees receive nonforfeitable dividends prior to vesting and, therefore, are included in the earnings allocation in computing EPS under the two-class method. Basic EPS excludes dilution and is computed by dividing income available to common shareholders by the weighted average number of common shares outstanding during the period. Diluted EPS is computed by dividing income available to common shareholders by the diluted weighted average number of common shares outstanding during the period, which includes the dilutive potential common shares associated with nonparticipating restricted stock and stock-settled stock appreciation rights.

Long-Term Debt

At December 31, 2013 and June 30, 2013, we had an unsecured credit agreement under which we may borrow, on a revolving credit basis, up to a maximum of $120 million at any one time, with potential to expand the total credit availability to $200 million based on obtaining consent of the issuing banks and certain other conditions. The facility expires on April 18, 2017, and all outstanding amounts are then due and payable. Interest is variable based upon formulas tied to LIBOR or an alternative base rate defined in the credit agreement, at our option. We must also pay facility fees that are tied to our then-applicable consolidated leverage ratio. Loans may be used for general corporate purposes. Based on the long-term nature of this facility, when we have outstanding borrowings under this facility, we will classify the outstanding balance as long-term debt.

Pension Benefits

We sponsor multiple defined benefit pension plans that have covered certain union workers. However, as a result of prior-years' restructuring activities, for all periods presented, we no longer have any active employees continuing to accrue service cost or otherwise eligible to receive plan benefits. Benefits being paid under the plans are primarily based on negotiated rates and years of service. We contribute to these plans at least the minimum amount required by regulation.

Postretirement Benefits

We and certain of our operating subsidiaries provide multiple postretirement medical and life insurance benefit plans. We recognize the cost of benefits as the employees render service. Postretirement benefits are funded as incurred.

XML

Document And Entity Information In Thousands, unless otherwise specified	6 Months Ended
	Dec. 31, 2013	Jan. 22, 2014
Document And Entity Information [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Fiscal Period Focus	Q2
Entity Central Index Key	0000057515
Entity Registrant Name	LANCASTER COLONY CORP
Entity Filer Category	Large Accelerated Filer
Entity Common Stock, Shares Outstanding		27,291
Document Period End Date	Dec. 31, 2013
Document Fiscal Year Focus	2014
Current Fiscal Year End Date	--06-30

XML

Summary Of Significant Accounting Policies (Tables)

6 Months Ended

Dec. 31, 2013

Accounting Policies [Abstract]

Schedule of Assets And Liabilities Of Sold Operations

The assets and liabilities of our sold operations were as follows:

	December 31,   2013		June 30,   2013
Cash	$	1	$	1
Receivables	26,594		14,061
Inventory	30,974		41,342
Other current assets	422		573
Property, plant and equipment	20,996		21,621
Other noncurrent assets	1,157		980
Total Assets	$	80,144	$	78,578
Accounts payable	$	4,029	$	5,431
Accrued liabilities	2,900		2,685
Total Liabilities	$	6,929	$	8,116

Schedule Of Construction In Progress In Accounts Payable

Purchases of property, plant and equipment included in accounts payable and excluded from the property additions and the change in accounts payable in the Condensed Consolidated Statements of Cash Flows were as follows:

	December 31,
	2013		2012
Construction in progress in accounts payable	$	70	$	3,393

Schedule Of Basic And Diluted Earnings Per Share Calculations

Basic and diluted net income per common share were calculated as follows:

	Three Months Ended   December 31,						Six Months Ended   December 31,
	2013			2012			2013			2012
Net income	$	39,234		$	35,277		$	64,035		$	61,939
Net income available to participating securities	(53		)	(246		)	(87		)	(299		)
Net income available to common shareholders	$	39,181		$	35,031		$	63,948		$	61,640
Weighted average common shares outstanding – basic	27,244			27,243			27,256			27,236
Incremental share effect from:
Nonparticipating restricted stock	3			4			4			4
Stock-settled stock appreciation rights	52			26			46			28
Weighted average common shares outstanding – diluted	27,299			27,273			27,306			27,268
Net income per common share – basic	$	1.44		$	1.29		$	2.35		$	2.26
Net income per common share – diluted	$	1.44		$	1.28		$	2.34		$	2.26

Schedule of Amounts Reclassified Out Of Accumulated Other Comprehensive Loss

The following table presents the amounts reclassified out of accumulated other comprehensive loss by component:

	Three Months Ended   December 31,						Six Months Ended   December 31,
	2013			2012			2013			2012
Accumulated other comprehensive loss at beginning of period	$	(8,324	)	$	(12,058	)	$	(8,391	)	$	(12,162	)
Defined Benefit Pension Plan Items:
Amortization of unrecognized net loss (1)	115			172			230			344
Postretirement Benefit Plan Items:
Amortization of unrecognized net gain (1)	(7		)	(5		)	(14		)	(10		)
Amortization of prior service asset (1)	(1		)	(1		)	(2		)	(2		)
Total other comprehensive income, before tax	107			166			214			332
Total tax expense	(39		)	(62		)	(79		)	(124		)
Other comprehensive income, net of tax	68			104			135			208
Accumulated other comprehensive loss at end of period	$	(8,256	)	$	(11,954	)	$	(8,256	)	$	(11,954	)

XML

Condensed Consolidated Statements Of Income (USD $) In Thousands, except Per Share data, unless otherwise specified	3 Months Ended		6 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2013	Dec. 31, 2012
Income Statement [Abstract]
Net Sales	$ 335,550	$ 326,155	$ 621,406	$ 617,131
Cost of Sales	247,242	244,499	471,460	469,758
Gross Margin	88,308	81,656	149,946	147,373
Selling, General and Administrative Expenses	28,937	29,031	52,975	54,176
Operating Income	59,371	52,625	96,971	93,197
Other Income:
Other income-Continued Dumping and Subsidy Offset Act	91	293	91	293
Interest income and other-net	(119)	(39)	(167)	(25)
Income Before Income Taxes	59,343	52,879	96,895	93,465
Taxes Based on Income	20,109	17,602	32,860	31,526
Net Income	$ 39,234	$ 35,277	$ 64,035	$ 61,939
Net Income Per Common Share:
Basic (in dollars per share)	$ 1.44	$ 1.29	$ 2.35	$ 2.26
Diluted (in dollars per share)	$ 1.44	$ 1.28	$ 2.34	$ 2.26
Cash Dividends Per Common Share (in dollars per share)	$ 0.44	$ 5.38	$ 0.84	$ 5.74
Weighted Average Common Shares Outstanding:
Basic (in shares)	27,244	27,243	27,256	27,236
Diluted (in shares)	27,299	27,273	27,306	27,268

XML

Stock-Based Compensation

6 Months Ended

Dec. 31, 2013

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

Stock-Based Compensation

Stock-Based Compensation

Our shareholders approved the adoption of and subsequent amendments to the Lancaster Colony Corporation 2005 Stock Plan (the “2005 Plan”). The 2005 Plan reserved 2,000,000 common shares for issuance to our employees and directors, and all awards granted under the 2005 Plan will be exercisable at prices not less than fair market value as of the date of the grant. The vesting period for awards granted under the 2005 Plan varies as to the type of award granted, but generally these awards have a maximum term of five years.

Stock-Settled Stock Appreciation Rights

We use periodic grants of stock-settled stock appreciation rights (“SSSARs”) as a vehicle for rewarding certain employees with long-term incentives for their efforts in helping to create long-term shareholder value. We calculate the fair value of SSSARs grants using the Black-Scholes option-pricing model. Our policy is to issue shares upon SSSARs exercise from new shares that had been previously authorized.

In August 2013, we granted SSSARs under the terms of our 2005 Plan. There were no grants in the six months ended December 31, 2012. The following table summarizes information relating to the 2014 grant:

	2014
SSSARs granted	2
Weighted average grant date fair value per right	$	10.14
Assumptions used in fair value calculations:
Risk-free interest rate	0.61		%
Dividend yield	2.01		%
Volatility factor of the expected market price of our common stock	23.00		%
Weighted average expected life in years	2.68
Estimated forfeiture rate	—		%

For this grant, the volatility factor was estimated based on actual historical volatility of our stock for a time period equal to the term of the SSSARs. The expected average life was determined based on historical exercise experience for this type of grant. The SSSARs from each grant vest one-third on the first anniversary of the grant date, one-third on the second anniversary of the grant date and one-third on the third anniversary of the grant date. No SSSARs vested during the six months ended December 31, 2013 and 2012.

We recognize compensation expense over the requisite service period. Compensation expense was reflected in Cost of Sales or Selling, General and Administrative Expenses based on the grantees’ salaries expense classification and was allocated to each segment appropriately. We recorded tax benefits and gross windfall tax benefits related to SSSARs. These windfall tax benefits were included in the financing section of the Condensed Consolidated Statements of Cash Flows. The following table summarizes SSSARs compensation expense and tax benefits recorded:

	Three Months Ended   December 31,				Six Months Ended   December 31,
	2013		2012		2013		2012
Compensation expense	$	212	$	338	$	519	$	799
Tax benefits	$	75	$	118	$	182	$	279
Intrinsic value of exercises	$	70	$	594	$	88	$	1,284
Gross windfall tax benefits	$	25	$	208	$	31	$	449

The following table summarizes the activity relating to SSSARs granted under the 2005 Plan for the six months ended December 31, 2013:

	Number of Rights		Weighted Average Exercise Price		Weighted Average Remaining Contractual Life in Years	Aggregate Intrinsic Value
Outstanding at beginning of period	374		$	66.42
Exercised	(7	)	$	61.48
Granted	2		$	79.78
Forfeited	—		$	—
Outstanding at end of period	369		$	66.57	3.03	$	7,966
Exercisable and vested at end of period	105		$	60.85	1.95	$	2,865
Vested and expected to vest at end of period	360		$	66.57	3.03	$	7,770

At December 31, 2013, there was approximately $1.0 million of unrecognized compensation expense related to SSSARs that we will recognize over a weighted-average period of approximately 1.64 years.

Restricted Stock

We use periodic grants of restricted stock as a vehicle for rewarding our nonemployee directors and certain employees with long-term incentives for their efforts in helping to create long-term shareholder value.

In November 2013 and 2012, we granted shares of restricted stock to our seven nonemployee directors under the terms of the 2005 Plan. The following table summarizes information relating to each of these grants:

	Six Months Ended   December 31,
	2013		2012
Nonemployee directors
Restricted stock granted	6		7
Grant date fair value	$	490	$	490
Weighted average grant date fair value per award	$	84.42	$	73.29

The 2014 grant vests over a one-year period, and all of these shares are expected to vest. Dividends earned on the stock during the vesting period will be paid to the directors at the time the stock vests. The 2013 grant vested during the second quarter of 2014, and the directors were paid the related dividends.

In August 2013, we granted 200 shares of restricted stock under the terms of the 2005 Plan. The grant date fair value was approximately $16,000 and the grant date fair value per award was $79.78. The restricted stock under this employee grant vests on the third anniversary of the grant date. Under the terms of our grants, employees receive dividends on unforfeited restricted stock regardless of their vesting status. There were no grants of restricted stock to employees in the six months ended December 31, 2012. No employee restricted stock vested during the six months ended December 31, 2013 and 2012.

We recognize compensation expense over the requisite service period. Compensation expense was reflected in Cost of Sales or Selling, General and Administrative Expenses based on the grantees’ salaries expense classification and was allocated to each segment appropriately. We recorded tax benefits and gross windfall tax benefits related to restricted stock. These windfall tax benefits were included in the financing section of the Condensed Consolidated Statements of Cash Flows. The following table summarizes restricted stock compensation expense and tax benefits recorded:

	Three Months Ended   December 31,				Six Months Ended   December 31,
	2013		2012		2013		2012
Compensation expense	$	341	$	414	$	681	$	824
Tax benefits	$	120	$	144	$	239	$	288
Gross windfall tax benefits	$	6	$	9	$	8	$	10

The total fair values of restricted stock vested were as follows:

	Six Months Ended   December 31,
	2013		2012
Fair value of vested shares	$	490	$	490

The following table summarizes the activity relating to restricted stock granted under the 2005 Plan for the six months ended December 31, 2013:

	Number of Shares		Weighted Average Grant Date Fair Value
Unvested restricted stock at beginning of period	45		$	68.16
Granted	6		$	84.27
Vested	(7	)	$	72.94
Forfeited	—		$	—
Unvested restricted stock at end of period	44		$	69.61

At December 31, 2013, there was approximately $1.5 million of unrecognized compensation expense related to restricted stock that we will recognize over a weighted-average period of approximately 1.34 years.

XML

Income Taxes

6 Months Ended

Dec. 31, 2013

Income Tax Disclosure [Abstract]

Income Taxes

Income Taxes

Accrued Federal income taxes of approximately $1.2 million were included in accrued liabilities, and prepaid state and local income taxes of approximately $0.6 million were included in deferred income taxes and other current assets, at December 31, 2013. Prepaid Federal, state and local income taxes of approximately $7.5 million were included in deferred income taxes and other current assets at June 30, 2013. The changes were due to the timing of tax payments.

The gross tax contingency reserve at December 31, 2013 was approximately $0.9 million and consisted of tax liabilities of approximately $0.5 million and penalties and interest of approximately $0.4 million. We have classified none of the gross tax contingency reserve as current liabilities as none of these amounts are expected to be resolved within the next 12 months. The entire liability of approximately $0.9 million was included in other noncurrent liabilities. We expect that the amount of these liabilities will change within the next 12 months; however, we do not expect the change to have a significant effect on our financial position or results of operations. We recognize interest and penalties related to these tax liabilities in income tax expense.

XML

Business Segments Information (Tables)

6 Months Ended

Dec. 31, 2013

Segment Reporting [Abstract]

Summary Of Financial Information Attributable To Reportable Segments

	Three Months Ended   December 31,						Six Months Ended   December 31,
	2013			2012			2013			2012
Net Sales
Specialty Foods	$	292,281		$	272,634		$	540,418		$	521,515
Glassware and Candles	43,269			53,521			80,988			95,616
Total	$	335,550		$	326,155		$	621,406		$	617,131
Operating Income
Specialty Foods	$	59,413		$	50,384		$	98,956		$	93,142
Glassware and Candles	3,186			5,614			4,355			6,222
Corporate Expenses	(3,228		)	(3,373		)	(6,340		)	(6,167		)
Total	$	59,371		$	52,625		$	96,971		$	93,197

XML

Goodwill And Other Intangible Assets (Tables)

6 Months Ended

Dec. 31, 2013

Goodwill and Intangible Assets Disclosure [Abstract]

Summary Of Intangible Assets

The following table summarizes our identifiable other intangible assets, all included in the Specialty Foods segment:

	December 31,   2013			June 30,   2013
Trademarks (40-year life)
Gross carrying value	$	370		$	370
Accumulated amortization	(209		)	(205		)
Net carrying value	$	161		$	165
Customer Relationships (12 to 15-year life)
Gross carrying value	$	13,020		$	13,020
Accumulated amortization	(7,332		)	(6,863		)
Net carrying value	$	5,688		$	6,157
Total net carrying value	$	5,849		$	6,322

Schedule Of Amortization Expense

Amortization expense for our intangible assets was as follows:

	Three Months Ended   December 31,				Six Months Ended   December 31,
	2013		2012		2013		2012
Amortization expense	$	237	$	236	$	473	$	472

Estimated Annual Amortization Expense

Total annual amortization expense for each of the next five years is estimated to be as follows:

2015	$	946
2016	$	775
2017	$	604
2018	$	604
2019	$	604

XML

Commitments And Contingencies

6 Months Ended

Dec. 31, 2013

Commitments and Contingencies Disclosure [Abstract]

Commitments And Contingencies

Commitments and Contingencies

At December 31, 2013, we were a party to various claims and litigation matters arising in the ordinary course of business. Such matters did not have a material effect on the current-year results of operations and, in our opinion, their ultimate disposition will not have a material effect on our consolidated financial statements.

The Continued Dumping and Subsidy Offset Act of 2000 (“CDSOA”) provides for the distribution of monies collected by U.S. Customs from anti-dumping cases to qualifying domestic producers. Our CDSOA receipts totaled approximately $0.1 million in the second quarter of 2014, as compared to approximately $0.3 million in the second quarter of 2013.

As of January 30, 2014, we sold substantially all of the net operating assets of our candle manufacturing and marketing operations to an unaffiliated buyer. While we retained the right to seek further CDSOA remittances relating to past periods, we are currently unaware of any funds made available to manufacturers who may have otherwise qualified for CDSOA remittances but have exited the applicable business. Accordingly, we cannot predict the amount of future distributions, if any, we may receive. U.S. Customs has advised affected domestic producers that it is possible that CDSOA distributions which we received could be subject to clawback until the resolution of outstanding litigation. We believe that the likelihood of clawback is remote. Any change in CDSOA distributions could affect our earnings and cash flow.

XML

Pension Benefits (Pension Benefits [Member])

6 Months Ended

Dec. 31, 2013

Pension Benefits [Member]

Defined Benefit Plan Disclosure [Line Items]

Pension Benefits

Pension Benefits

We sponsor multiple defined benefit pension plans that have covered certain union workers. However, as a result of prior-years' restructuring activities, for all periods presented, we no longer have any active employees continuing to accrue service cost or otherwise eligible to receive plan benefits. Benefits being paid under the plans are primarily based on negotiated rates and years of service. We contribute to these plans at least the minimum amount required by regulation.

The following table summarizes the components of net periodic benefit income for our pension plans:

	Three Months Ended   December 31,						Six Months Ended   December 31,
	2013			2012			2013			2012
Components of net periodic benefit income
Interest cost	$	438		$	408		$	876		$	816
Expected return on plan assets	(614		)	(595		)	(1,228		)	(1,190		)
Amortization of unrecognized net loss	115			172			230			344
Net periodic benefit income	$	(61	)	$	(15	)	$	(122	)	$	(30	)

For the three and six months ended December 31, 2013, we made no pension plan contributions and we expect to make no contributions to our pension plans during 2014.

XML

Postretirement Benefits (Postretirement Benefits [Member])

6 Months Ended

Dec. 31, 2013

Postretirement Benefits [Member]

Defined Benefit Plan Disclosure [Line Items]

Postretirement Benefits

Postretirement Benefits

We and certain of our operating subsidiaries provide multiple postretirement medical and life insurance benefit plans. We recognize the cost of benefits as the employees render service. Postretirement benefits are funded as incurred.

The following table summarizes the components of net periodic benefit cost for our postretirement plans:

	Three Months Ended   December 31,						Six Months Ended   December 31,
	2013			2012			2013			2012
Components of net periodic benefit cost
Service cost	$	8		$	8		$	16		$	16
Interest cost	32			28			64			56
Amortization of unrecognized net gain	(7		)	(5		)	(14		)	(10		)
Amortization of prior service asset	(1		)	(1		)	(2		)	(2		)
Net periodic benefit cost	$	32		$	30		$	64		$	60

For the three and six months ended December 31, 2013, we made approximately $40,000 and $65,000 in contributions to our postretirement medical and life insurance benefit plans. We expect to make approximately $0.1 million more in contributions to our postretirement medical and life insurance benefit plans during the remainder of 2014.

XML

Business Segments Information

6 Months Ended

Dec. 31, 2013

Segment Reporting [Abstract]

Business Segments Information

Business Segments Information

The following summary of financial information by business segment is consistent with the basis of segmentation and measurement of segment profit or loss presented in our June 30, 2013 consolidated financial statements. The December 31, 2013 identifiable assets by reportable segment are generally consistent with that of June 30, 2013.

	Three Months Ended   December 31,						Six Months Ended   December 31,
	2013			2012			2013			2012
Net Sales
Specialty Foods	$	292,281		$	272,634		$	540,418		$	521,515
Glassware and Candles	43,269			53,521			80,988			95,616
Total	$	335,550		$	326,155		$	621,406		$	617,131
Operating Income
Specialty Foods	$	59,413		$	50,384		$	98,956		$	93,142
Glassware and Candles	3,186			5,614			4,355			6,222
Corporate Expenses	(3,228		)	(3,373		)	(6,340		)	(6,167		)
Total	$	59,371		$	52,625		$	96,971		$	93,197

As a result of the sale of assets noted in the Subsequent Events disclosure within Note 1, the Glassware and Candles segment will be presented as discontinued operations in future financial presentations.

XML

Income Taxes (Details) (USD $) In Millions, unless otherwise specified	Dec. 31, 2013	Jun. 30, 2013
Income Tax Disclosure [Abstract]
Accrued income taxes	$ 1.2
Prepaid taxes	0.6	7.5
Gross tax contingency reserve	0.9
Accrued tax liabilities included in the gross tax contingency reserve	0.5
Accrued interest and penalties included in the gross tax contingency reserve	0.4
Gross tax contingency reserve, classified as current liabilities	0
Gross tax contingency reserve, classified as noncurrent liabilities	$ 0.9

XML

Pension Benefits (Tables) (Pension Benefits [Member])

6 Months Ended

Dec. 31, 2013

Pension Benefits [Member]

Defined Benefit Plan Disclosure [Line Items]

Components Of Net Periodic Benefit Income

The following table summarizes the components of net periodic benefit income for our pension plans:

	Three Months Ended   December 31,						Six Months Ended   December 31,
	2013			2012			2013			2012
Components of net periodic benefit income
Interest cost	$	438		$	408		$	876		$	816
Expected return on plan assets	(614		)	(595		)	(1,228		)	(1,190		)
Amortization of unrecognized net loss	115			172			230			344
Net periodic benefit income	$	(61	)	$	(15	)	$	(122	)	$	(30	)

XML

Summary Of Significant Accounting Policies (Schedule Of Construction In Progress In Accounts Payable) (Details) (USD $) In Thousands, unless otherwise specified	6 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Accounting Policies [Abstract]
Construction in progress in accounts payable	$ 70	$ 3,393

XML

Stock-Based Compensation (Fair Value of Restricted Stock Vested) (Details) (Restricted Stock [Member], USD $) In Thousands, unless otherwise specified	6 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Restricted Stock [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Fair value of vested shares	$ 490	$ 490

XML

Condensed Consolidated Statements Of Comprehensive Income (USD $) In Thousands, unless otherwise specified	3 Months Ended		6 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2013	Dec. 31, 2012
Statement of Comprehensive Income [Abstract]
Net Income	$ 39,234	$ 35,277	$ 64,035	$ 61,939
Defined Benefit Pension and Postretirement Benefit Plans:
Amortization of loss, before tax	108	167	216	334
Amortization of prior service asset, before tax	(1)	(1)	(2)	(2)
Total Other Comprehensive Income, Before Tax	107	166	214	332
Tax Attributes of Items in Other Comprehensive Income:
Amortization of loss, tax	(39)	(62)	(79)	(124)
Amortization of prior service asset, tax	0	0	0	0
Total Tax Expense	(39)	(62)	(79)	(124)
Other comprehensive income, net of tax	68	104	135	208
Comprehensive Income	$ 39,302	$ 35,381	$ 64,170	$ 62,147

XML

Long-Term Debt

6 Months Ended

Dec. 31, 2013

Debt Disclosure [Abstract]

Long-Term Debt

Long-Term Debt

At December 31, 2013 and June 30, 2013, we had an unsecured credit agreement under which we may borrow, on a revolving credit basis, up to a maximum of $120 million at any one time, with potential to expand the total credit availability to $200 million based on obtaining consent of the issuing banks and certain other conditions. The facility expires on April 18, 2017, and all outstanding amounts are then due and payable. Interest is variable based upon formulas tied to LIBOR or an alternative base rate defined in the credit agreement, at our option. We must also pay facility fees that are tied to our then-applicable consolidated leverage ratio. Loans may be used for general corporate purposes. Based on the long-term nature of this facility, when we have outstanding borrowings under this facility, we will classify the outstanding balance as long-term debt.

At December 31, 2013 and June 30, 2013, we had no borrowings outstanding under this facility. At December 31, 2013, we had approximately $3.7 million of standby letters of credit outstanding, which reduced the amount available for borrowing under the credit agreement. We paid no interest for the three and six months ended December 31, 2013 and 2012. At December 31, 2013 and June 30, 2013, we were in compliance with all applicable provisions and covenants of this facility, and we exceeded the requirements of the financial covenants by substantial margins. At December 31, 2013, we were not aware of any event that would constitute a default under the facility.

The facility contains certain restrictive covenants, including limitations on indebtedness, asset sales and acquisitions. There are two principal financial covenants: an interest expense test that requires us to maintain an interest coverage ratio not less than 2.5 to 1 at the end of each fiscal quarter; and an indebtedness test that requires us to maintain a consolidated leverage ratio not greater than 3 to 1 at all times. The interest coverage ratio is calculated by dividing Consolidated EBIT (as defined more specifically in the credit agreement) by Consolidated Interest Expense (as defined more specifically in the credit agreement), and the leverage ratio is calculated by dividing Consolidated Debt (as defined more specifically in the credit agreement) by Consolidated EBITDA (as defined more specifically in the credit agreement).

XML

Summary Of Significant Accounting Policies (Schedule Of Basic And Diluted Earnings Per Share Calculations) (Details) (USD $) In Thousands, except Per Share data, unless otherwise specified	3 Months Ended		6 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2013	Dec. 31, 2012
Accounting Policies [Abstract]
Net income	$ 39,234	$ 35,277	$ 64,035	$ 61,939
Net income available to participating securities	(53)	(246)	(87)	(299)
Net income available to common shareholders	$ 39,181	$ 35,031	$ 63,948	$ 61,640
Weighted average common shares outstanding - basic (in shares)	27,244	27,243	27,256	27,236
Incremental share effect from:
Nonparticipating restricted stock (in shares)	3	4	4	4
Stock-settled stock appreciation rights (in shares)	52	26	46	28
Weighted average common shares outstanding - diluted (in shares)	27,299	27,273	27,306	27,268
Net income per common share - basic (in dollars per share)	$ 1.44	$ 1.29	$ 2.35	$ 2.26
Net income per common share - diluted (in dollars per share)	$ 1.44	$ 1.28	$ 2.34	$ 2.26

XML

Stock-Based Compensation (Stock-Settled Stock Appreciation Rights Activity) (Details) (Stock Settled Stock Appreciation Rights SARS [Member], USD $) In Thousands, except Share data, unless otherwise specified	6 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Stock Settled Stock Appreciation Rights SARS [Member]
Number of Rights
Number of Rights, Outstanding at beginning of period	374,000
Number of Rights, Exercised	(7,000)
Number of Rights, Granted	2,000	0
Number of Rights, Forfeited	0
Number of Rights, Outstanding at end of period	369,000
Number of Rights, Exercisable and vested at end of period	105,000
Number of Rights, Vested and expected to vest at end of period	360,000
Weighted Average Exercise Price
Weighted Average Exercise Price, Outstanding at beginning of period	$ 66.42
Weighted Average Exercise Price, Exercised	$ 61.48
Weighted Average Exercise Price, Granted	$ 79.78
Weighted Average Exercise Price, Forfeited	$ 0.00
Weighted Average Exercise Price, Outstanding at end of period	$ 66.57
Weighted Average Exercise Price, Exercisable and vested at end of period	$ 60.85
Weighted Average Exercise Price, Vested and expected to vest at end of period	$ 66.57
Weighted Average Remaining Contractual Life in Years, Outstanding at end of period	3 years 11 days
Weighted Average Remaining Contractual Life in Years, Exercisable and vested at end of period	1 year 11 months 12 days
Weighted Average Remaining Contractual Life in Years, Vested and expected to vest at end of period	3 years 11 days
Aggregate Intrinsic Value, Outstanding at end of period	$ 7,966
Aggregate Intrinsic Value, Exercisable and vested at end of period	2,865
Aggregate Intrinsic Value, Vested and expected to vest at end of period	$ 7,770

XML

Stock-Based Compensation (Tables)

6 Months Ended

Dec. 31, 2013

Stock Settled Stock Appreciation Rights SARS [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Stock-Settled Stock Appreciation Rights Grant Details

The following table summarizes information relating to the 2014 grant:

	2014
SSSARs granted	2
Weighted average grant date fair value per right	$	10.14
Assumptions used in fair value calculations:
Risk-free interest rate	0.61		%
Dividend yield	2.01		%
Volatility factor of the expected market price of our common stock	23.00		%
Weighted average expected life in years	2.68
Estimated forfeiture rate	—		%

Compensation Expense And Tax Benefits Recorded

The following table summarizes SSSARs compensation expense and tax benefits recorded:

	Three Months Ended   December 31,				Six Months Ended   December 31,
	2013		2012		2013		2012
Compensation expense	$	212	$	338	$	519	$	799
Tax benefits	$	75	$	118	$	182	$	279
Intrinsic value of exercises	$	70	$	594	$	88	$	1,284
Gross windfall tax benefits	$	25	$	208	$	31	$	449

Stock-Settled Stock Appreciation Rights Activity

The following table summarizes the activity relating to SSSARs granted under the 2005 Plan for the six months ended December 31, 2013:

	Number of Rights		Weighted Average Exercise Price		Weighted Average Remaining Contractual Life in Years	Aggregate Intrinsic Value
Outstanding at beginning of period	374		$	66.42
Exercised	(7	)	$	61.48
Granted	2		$	79.78
Forfeited	—		$	—
Outstanding at end of period	369		$	66.57	3.03	$	7,966
Exercisable and vested at end of period	105		$	60.85	1.95	$	2,865
Vested and expected to vest at end of period	360		$	66.57	3.03	$	7,770

Director Restricted Stock [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Schedule Of Restricted Stock Granted To Nonemployee Directors

The following table summarizes information relating to each of these grants:

	Six Months Ended   December 31,
	2013		2012
Nonemployee directors
Restricted stock granted	6		7
Grant date fair value	$	490	$	490
Weighted average grant date fair value per award	$	84.42	$	73.29

Restricted Stock [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Compensation Expense And Tax Benefits Recorded

The following table summarizes restricted stock compensation expense and tax benefits recorded:

	Three Months Ended   December 31,				Six Months Ended   December 31,
	2013		2012		2013		2012
Compensation expense	$	341	$	414	$	681	$	824
Tax benefits	$	120	$	144	$	239	$	288
Gross windfall tax benefits	$	6	$	9	$	8	$	10

Fair Value Of Awards Vested

The total fair values of restricted stock vested were as follows:

	Six Months Ended   December 31,
	2013		2012
Fair value of vested shares	$	490	$	490

Restricted Stock Activity

The following table summarizes the activity relating to restricted stock granted under the 2005 Plan for the six months ended December 31, 2013:

	Number of Shares		Weighted Average Grant Date Fair Value
Unvested restricted stock at beginning of period	45		$	68.16
Granted	6		$	84.27
Vested	(7	)	$	72.94
Forfeited	—		$	—
Unvested restricted stock at end of period	44		$	69.61